Personale

Recapiti

Italiano

Curriculum

Pubblicazioni

Insegnamenti

Alberto BOSI

Ruolo attuale:: Professore Ordinario Onorario
SSD:: MED/15 - Malattie del sangue
Afferenza organizzativa:: Dipartimento di Medicina Sperimentale e Clinica

Recapiti

	0554277067
	alberto.bosi(AT)unifi.it

Alberto BOSI

Pubblicazioni

Legenda

Contributo su rivista |

Articolo su libro |

Libro |

Contributo in atti di convegno (proceeding) |

Brevetto |

Curatela | Altro

Altro |

Tesi di Dottorato

Perrone, Gabriele; Rigacci, Luigi; Roviello, Giandomenico; Landini, Ida; Fabbri, Alberto; Iovino, Lorenzo; Puccini, Benedetta; Cencini, Emanuele; Orciuolo, Enrico; Bocchia, Monica; Bosi, Alberto; Mini, Enrico; Nobili, Stefania (2024). Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients. CANCER DRUG RESISTANCE, vol. 7, pp. 1-14, ISSN:2578-532X DOI

Perrone, Gabriele; Rigacci, Luigi; Urru, Sara; Kovalchuk, Sofya; Brugia, Marco; Fabbri, Alberto; Iovino, Lorenzo; Puccini, Benedetta; Cencini, Emanuele; Orciuolo, Enrico; Birtolo, Silvia; Melosi, Alessandro; Santini, Simone; Landini, Ida; Roviello, Giandomenico; Santi, Raffaella; Macciotta, Alessandra; Ricceri, Fulvio; Bosi, Alberto; Bocchia, Monica; Petrini, Mario; Mini, Enrico; Nobili, Stefania (2023). Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma. CANCERS, vol. 15, pp. 0-0, ISSN:2072-6694 DOI

Miraglia Raineri A.; Lauro Grotto R.; Fioravanti G.; Rotella F.; Alterini R.; Bosi A.; Faravelli C. (2022). Underestimated Needs for Lymphoma Patients: An Assessment Issue. ACTA BIOMEDICA, vol. 93, pp. 0-0, ISSN:2531-6745 DOI

Pisano L.; Di Pietro M.; Santi R.; Grandi V.; Bosi A.; Santucci M.; Pimpinelli N.; Difonzo E.M. (2021). Non-scarring patchy alopecia: What else, apart from alopecia areata?. JOURNAL OF CUTANEOUS PATHOLOGY, vol. 48, pp. 1282-1285, ISSN:0303-6987 DOI

Weisel K.; Spencer A.; Lentzsch S.; Avet-Loiseau H.; Mark T.M.; Spicka I.; Masszi T.; Lauri B.; Levin M.-D.; Bosi A.; Hungria V.; Cavo M.; Lee J.-J.; Nooka A.; Quach H.; Munder M.; Lee C.; Barreto W.; Corradini P.; Min C.-K.; Chanan-Khan A.A.; Horvath N.; Capra M.; Beksac M.; Ovilla R.; Jo J.-C.; Shin H.-J.; Sonneveld P.; Casneuf T.; DeAngelis N.; Amin H.; Ukropec J.; Kobos R.; Mateos M.-V. (2020). Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk. JOURNAL OF HEMATOLOGY & ONCOLOGY, vol. 13, pp. 115-120, ISSN:1756-8722 DOI

Gianfaldoni, Giacomo; Mannelli, Francesco; Intermesoli, Tamara; Bencini, Sara; Giupponi, Damiano; Farina, Giorgio; Cutini, Ilaria; Bonetti, Maria Ida; Masciulli, Arianna; Audisio, Ernesta; Ferrero, Dario; Pavoni, Chiara; Scattolin, Anna Maria; Bosi, Alberto; Rambaldi, Alessandro; Bassan, Renato (2020). Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial. BLOOD ADVANCES, vol. 4, pp. 301-311-311, ISSN:2473-9529 DOI

Staderini, Michela; Mannelli, Lara; Antonioli, Elisabetta; Puccini, Benedetta; Berti, Valentina; Mungai, Francesco; Vergoni, Federica; Carrai, Valentina; Rigacci, Luigi; Bosi, Alberto (2020). Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation. CASE REPORTS IN HEMATOLOGY, vol. 2020, pp. 736-737, ISSN:2090-6560 DOI

Antonioli, Elisabetta; Staderini, Michela; Pilerci, Sofia; Perfetto, Federico; Cappelli, Francesco; Allinovi, Marco; Nozzoli, Chiara; Attucci, Irene; Buzzichelli, Alessandra; Messeri, Maria; Bosi, Alberto (2020). Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience. LEUKEMIA & LYMPHOMA, pp. 1-4-4, ISSN:1042-8194 DOI

Coltro, Giacomo; Mannelli, Francesco; Vergoni, Federica; Santi, Raffaella; Massi, Daniela; Siliani, Luisa Margherita; Marzullo, Antonella; Bonifacio, Stefania; Pelo, Elisabetta; Pacilli, Annalisa; Paoli, Chiara; Franci, Annalisa; Calabresi, Laura; Bosi, Alberto; Vannucchi, Alessandro Maria; Guglielmelli, Paola (2020). Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature. CLINICAL AND EXPERIMENTAL MEDICINE, pp. 203-210, ISSN:1591-8890 DOI

Coltro, Giacomo; Antelo, Guadalupe; Lasho, Terra L; Finke, Christy M; Pardanani, Animesh; Gangat, Naseema; Carr, Ryan M; Binder, Moritz; Mangaonkar, Abhishek A; Ketterling, Rhett; Fernandez-Zapico, Martin E; Robertson, Keith D; Bosi, Alberto; Vannucchi, Alessandro M; Tefferi, Ayalew; Patnaik, Mrinal M (2020). Phenotypic Correlates and Prognostic Outcomes of TET2 Mutations in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A Comprehensive Study of 504 Adult Patients. AMERICAN JOURNAL OF HEMATOLOGY, pp. 222-230, ISSN:0361-8609 DOI

Mannelli, Francesco; Gianfaldoni, Giacomo; Bencini, Sara; Piccini, Matteo; Cutini, Ilaria; Bonetti, Maria Ida; Scappini, Barbara; Pancani, Fabiana; Ponziani, Vanessa; Chiarini, Marco; Borlenghi, Erika; Bassan, Renato; Rossi, Giuseppe; Bosi, Alberto (2020). Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in AML. AMERICAN JOURNAL OF HEMATOLOGY, pp. 25-30, ISSN:0361-8609 DOI

Hochhaus, Andreas; Gambacorti-Passerini, Carlo; Abboud, Camille; Gjertsen, Bjørn Tore; Brümmendorf, Tim H; Smith, B Douglas; Ernst, Thomas; Giraldo-Castellano, Pilar; Olsson-Strömberg, Ulla; Saussele, Susanne; Bardy-Bouxin, Nathalie; Viqueira, Andrea; Leip, Eric; Russell-Smith, T Alexander; Leone, Jocelyn; Rosti, Gianantonio; Watts, Justin; Giles, Francis J; Bosi, Alberto (2020). Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study. LEUKEMIA, pp. 107-111, ISSN:0887-6924 DOI

Santopietro, Michelina; Kovalchuk, Sofia; Battistini, Roberta; Puccini, Benedetta; Annibali, Ombretta; Romano, Ilaria; Zoli, Valerio; Avvisati, Giuseppe; Bosi, Alberto; Rigacci, Luigi (2020). Treatment and prognosis of primary pulmonary lymphoma: a long-term follow-up study. EUROPEAN JOURNAL OF HAEMATOLOGY, pp. 20-27, ISSN:0902-4441 DOI

Mullane, Kathleen M; Morrison, Vicki A; Camacho, Luis H; Arvin, Ann; McNeil, Shelly A; Durrand, Jessie; Campbell, Bernadette; Su, Shu-Chih; Chan, Ivan S F; Parrino, Janie; Kaplan, Susan S; Popmihajlov, Zoran; Annunziato, Paula W, Bosi A (2019). Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial. THE LANCET INFECTIOUS DISEASES, pp. 25-35, ISSN:1473-3099 DOI

Antonioli, Elisabetta; Fani, Arianna; Sordi, Benedetta; Puccini, Benedetta; Bosi, Alberto (2019). Chemotherapy-related nail toxicity. INTERNATIONAL JOURNAL OF HEMATOLOGY, pp. 25-30, ISSN:0925-5710 DOI

Innocenti, Rolando; Rigacci, Luigi; Restelli, Umberto; Scappini, Barbara; Gianfaldoni, Giacomo; Fanci, Rosa; Mannelli, Francesco; Scolari, Francesca; Croce, Davide; Bonizzoni, Erminio; Perrone, Tania; Bosi, Alberto (2019). Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey. JOURNAL OF BLOOD MEDICINE, vol. 10, pp. 21-27, ISSN:1179-2736, DOVE MEDICAL PRESS LTD: DOI

Baron, Frédéric; Efficace, Fabio; Cannella, Laura; Willemze, Roel; Vignetti, Marco; Muus, Petra; Marie, Jean-Pierre; Ferrero, Dario; Fazi, Paola; La Sala, Edoardo; Bourhis, Jean-Henri; Fabbiano, Francesco; Bosi, Alberto; Sborgia, Marco; Martinelli, Giovanni; Wittnebel, Sebastian; Trisolini, Silvia; Petti, Maria Concetta; Halkes, Constantijn J M; van der Velden, Walter J F M; de Witte, Theo; Amadori, Sergio; Zittoun, Robert A; Suciu, Stefan (2019). Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients. HAEMATOLOGICA, pp. haematol.2019.221333-54, ISSN:0390-6078 DOI

Baron, Frédéric; Labopin, Myriam; Ruggeri, Annalisa; Ehninger, Gerhard; Bonifazi, Fransesca; Stelljes, Matthias; Sanz, Jaime; Stuhler, Gernot; Bosi, Alberto; Kröger, Nicolaus; Van Lint, Maria Teresa; Ganser, Arnold; Forcade, Edouard; Mohty, Mohamad; Gluckman, Eliane; Nagler, Arnon (2019). Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT. BLOOD CANCER JOURNAL, vol. 9, pp. 46-50, ISSN:2044-5385 DOI

Antonioli, Elisabetta; Nozzoli, Chiara; Buda, Gabriele; Staderini, Michela; Boncompagni, Riccardo; Martini, Francesca; Petrini, Mario; Bosi, Alberto; Saccardi, Riccardo (2019). Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients. EUROPEAN JOURNAL OF HAEMATOLOGY, pp. 200-208, ISSN:0902-4441 DOI

Derenzini, E; Risso, A; Ruella, M; Spatola, T; Milone, G; Pioltelli, P; Iori, A P; Santarone, S; Bosi, A; Rambaldi, A; Bacigalupo, A P; Arcese, W; Tarella, C (2019). INFLUENCE OF DONOR AND RECIPIENT GENDER ON TELOMERE MAINTENANCE FOLLOWING UMBILICAL CORD BLOOD CELL TRANSPLANTATION: A STUDY BY GITMO (GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, pp. 34-42, ISSN:1083-8791 DOI

Bassan, Renato; Intermesoli, Tamara; Masciulli, Arianna; Pavoni, Chiara; Boschini, Cristina; Gianfaldoni, Giacomo; Marmont, Filippo; Cavattoni, Irene; Mattei, Daniele; Terruzzi, Elisabetta; De Paoli, Lorella; Cattaneo, Chiara; Borlenghi, Erika; Ciceri, Fabio; Bernardi, Massimo; Scattolin, Anna M; Todisco, Elisabetta; Campiotti, Leonardo; Corradini, Paolo; Cortelezzi, Agostino; Ferrero, Dario; Zanghì, Pamela; Oldani, Elena; Spinelli, Orietta; Audisio, Ernesta; Cortelazzo, Sergio; Bosi, Alberto; Falini, Brunangelo; Pogliani, Enrico M; Rambaldi, Alessandro (2019). Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. BLOOD ADVANCES, vol. 3, pp. 1103-1117-1117, ISSN:2473-9529 DOI

Facon, Thierry; Kumar, Shaji; Plesner, Torben; Orlowski, Robert Z; Moreau, Philippe; Bahlis, Nizar; Basu, Supratik; Nahi, Hareth; Hulin, Cyrille; Quach, Hang; Goldschmidt, Hartmut; O'Dwyer, Michael; Perrot, Aurore; Venner, Christopher P; Weisel, Katja; Mace, Joseph R; Raje, Noopur; Attal, Michel; Tiab, Mourad; Macro, Margaret; Frenzel, Laurent; Leleu, Xavier; Ahmadi, Tahamtan; Chiu, Christopher; Wang, Jianping; Van Rampelbergh, Rian; Uhlar, Clarissa M; Kobos, Rachel; Qi, Ming; Usmani, Saad Z, Bosi A (2019). Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma. THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 380, pp. 2104-2115-2115, ISSN:0028-4793 DOI

Coltro, Giacomo; Mangaonkar, Abhishek A; Lasho, Terra L; Finke, Christy M; Pophali, Prateek; Carr, Ryan; Gangat, Naseema; Binder, Moritz; Pardanani, Animesh; Fernandez-Zapico, Martin; Robertson, Keith D; Bosi, Alberto; Droin, Nathalie; Vannucchi, Alessandro M; Tefferi, Ayalew; Hunter, Anthony; Padron, Eric; Solary, Eric; Patnaik, Mrinal M (2019). Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients. LEUKEMIA, pp. 78-85, ISSN:0887-6924 DOI

Abruzzese, Elisabetta; Bosi, Alberto; Breccia, Massimo; D'Adda, Mariella; Di Renzo, Nicola; Liberati, Anna Marina; Porrini, Raffaele; Orlandi, Ester Maria; Pane, Fabrizio; Pungolino, Ester; Sorà, Federica; Stagno, Fabio; Sen, Ginny P; Gentilini, Fabiana; De Solda, Francesco; Gambacorti-Passerini, Carlo (2019). Treatment Patterns in Patients with Chronic-Phase Chronic Myeloid Leukaemia in Routine Clinical Practice: the SIMPLICITY Italian Population. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, vol. 11, pp. e2019025-027, ISSN:2035-3006 DOI

Mohty, Mohamad; Terpos, Evangelos; Mateos, Maria-Victoria; Cavo, Michele; Lejniece, Sandra; Beksac, Meral; Bekadja, Mohamed Amine; Legiec, Wojciech; Dimopoulos, Meletios; Stankovic, Svetlana; Durán, Maria Soledad; De Stefano, Valerio; Corso, Alessandro; Kochkareva, Yulia; Laane, Edward; Berthou, Christian; Salwender, Hans; Masliak, Zvenyslava; Pečeliūnas, Valdas; Willenbacher, Wolfgang; Silva, João; Louw, Vernon; Nemet, Damir; Borbényi, Zita; Abadi, Uri; Pedersen, Robert Schou; Černelč, Peter; Potamianou, Anna; Couturier, Catherine; Feys, Caroline; Thoret-Bauchet, Florence; Boccadoro, Mario, Bosi alberto (2018). Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. +, pp. 30230-30231, ISSN:2152-2650 DOI

Patriarca, Francesca; Masciulli, Arianna; Bacigalupo, Andrea; Bregante, Stefania; Pavoni, Chiara; Finazzi, Maria Chiara; Bosi, Alberto; Russo, Domenico; Narni, Franco; Messina, Giuseppe; Alessandrino, Emilio Paolo; Carella, Angelo Michele; Milone, Giuseppe; Bruno, Benedetto; Mammoliti, Sonia; Bruno, Barbara; Fanin, Renato; Bonifazi, Francesca; Rambaldi, Alessandro (2018). Busulfan or thiotepa based conditioning in myelofibrosis: a phase II multicenter randomized study from the GITMO group. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, pp. 315-320, ISSN:1083-8791 DOI

Spencer, Andrew; Lentzsch, Suzanne; Weisel, Katja; Avet-Loiseau, Hervé; Mark, Tomer M; Spicka, Ivan; Masszi, Tamas; Lauri, Birgitta; Levin, Mark-David; Bosi, Alberto; Hungria, Vania; Cavo, Michele; Lee, Je-Jung; Nooka, Ajay K; Quach, Hang; Lee, Cindy; Barreto, Wolney; Corradini, Paolo; Min, Chang-Ki; Scott, Emma C; Chanan-Khan, Asher A; Horvath, Noemi; Capra, Marcelo; Beksac, Meral; Ovilla, Roberto; Jo, Jae-Cheol; Shin, Ho-Jin; Sonneveld, Pieter; Soong, David; Casneuf, Tineke; Chiu, Christopher; Amin, Himal; Qi, Ming; Thiyagarajah, Piruntha; Sasser, A Kate; Schecter, Jordan M; Mateos, Maria-Victoria (2018). Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR. HAEMATOLOGICA, pp. haematol.2018.194118-120, ISSN:0390-6078 DOI

Dimopoulos, Meletios A; Gay, Francesca; Schjesvold, Fredrik; Beksac, Meral; Hajek, Roman; Weisel, Katja Christina; Goldschmidt, Hartmut; Maisnar, Vladimir; Moreau, Philippe; Min, Chang Ki; Pluta, Agnieszka; Chng, Wee-Joo; Kaiser, Martin; Zweegman, Sonja; Mateos, Maria-Victoria; Spencer, Andrew; Iida, Shinsuke; Morgan, Gareth; Suryanarayan, Kaveri; Teng, Zhaoyang; Skacel, Tomas; Palumbo, Antonio; Dash, Ajeeta B; Gupta, Neeraj; Labotka, Richard; Rajkumar, S Vincent, Bosi a (2018). Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial. THE LANCET, pp. 207-211, ISSN:0140-6736 DOI

Loscocco, Giuseppe G; Piccini, Matteo; Vergoni, Federica; Vannucchi, Alessandro M; Bosi, Alberto (2018). A case of disseminated Blastic Plasmocytoid Dendritic Cell Neoplasm. AMERICAN JOURNAL OF HEMATOLOGY, pp. 25-28, ISSN:0361-8609 DOI

Tefferi, Ayalew; Mudireddy, Mythri; Mannelli, Francesco; Begna, Kebede H; Patnaik, Mrinal M; Hanson, Curtis A; Ketterling, Rhett P; Gangat, Naseema; Yogarajah, Meera; De Stefano, Valerio; Passamonti, Francesco; Rosti, Vittorio; Finazzi, Maria Chiara; Rambaldi, Alessandro; Bosi, Alberto; Guglielmelli, Paola; Pardanani, Animesh; Vannucchi, Alessandro M (2018). Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts. LEUKEMIA, pp. 280-290, ISSN:1476-5551 DOI

Christopeit, Maximilian; Labopin, Myriam; Gorin, Norbert-Claude; Saraceni, Francesco; Passweg, Jakob; Forcade, Edouard; Maertens, Johan; Van Lint, Maria Teresa; Bosi, Alberto; Niederwieser, Dietger; Ehninger, Gerhard; Polge, Emmanuelle; Mohty, Mohamad; Nagler, Arnon (2018). Allogeneic Stem Cell Transplantation following Relapse post Autologous Stem Cell Transplantation in adult patients with Acute Myeloid Leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT. AMERICAN JOURNAL OF HEMATOLOGY, pp. 285-290, ISSN:0361-8609 DOI

Rigacci, Luigi; Kovalchuk, Sofia; Berti, Valentina; Puccini, Benedetta; Mannelli, Lara; Benelli, Gemma; Dini, Catia; Pupi, Alberto; Bosi, Alberto (2018). The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas. WORLD JOURNAL OF NUCLEAR MEDICINE, vol. 17, pp. 157-165, ISSN:1450-1147 DOI

Winston, Drew J*; Mullane, Kathleen M; Cornely, Oliver A; Boeckh, Michael J; Brown, Janice Wes; Pergam, Steven A; Trociukas, Igoris; Žák, Pavel; Craig, Michael D; Papanicolaou, Genovefa A; Velez, Juan D; Panse, Jens; Hurtado, Kimberly; Fernsler, Doreen A; Stek, Jon E; Pang, Lei; Su, Shu-Chih; Zhao, Yanli; Chan, Ivan S F; Kaplan, Susan S; Parrino, Janie; Lee, Ingi; Popmihajlov, Zoran; Annunziato, Paula W; Arvin, Ann; Basso, A.C.; Bonvehi, P.; Cerana, S.; Dictar, M.O.; Campbell, P.; Playford, G.; Sasadeusz, J.; Maertens, J.; Poire, X.; Sellesag, D.; Schots, R.; Theunissen, K.; Willems, E.; Alves, R.S.; Camargo, J.F.C.; Castro, N.S.; Maria Fogliatto, L.; Rodrigo, O.; Courture, F.; McGeer, A.; Miller, M.; Combariza, J.F.; Sossa, C.L.; Velez, J.D.; Nemet, D.; Ostojic Kolonic, S.; Jebavy, L.; Mayer, J.; Novak, J.; Pohlreich, D.; Maldonado, B.; Gastinne, T.; Karlin, L.; Launay, O.; Cornely, O.A.; Duerk, H.A.; Haenel, M.; Heinz, W.; Kaufmann, M.; Panse, J.; Teschner, D.; Verbeek, M.; Wulf, G.; Aviv, F.; Grisariu, S.; Nagler, A.; Yeshurun, M.; Bosi, A.; Corradini, P.; Martinelli, G.; Onida, F.; Rambaldi, A.; Velardi, A.; Trociukas, I.; Gomez, A.D.; Wondergem, M.J.; Ypma, P.F.; Fanilla, E.; Moreno Larrea, M.D.C.; Abecasis, M.M.; Ferreira, R.B.; Geraldes, C.; Castro, J.; Afanasyev, B.V.; Kruchkova, I.V.; Zaritskiy, A.Y.; Cheong, J.W.; Kim, S.J.; Lee, D.G.; Yoon, S.S.; Aguado Bueno, B.; Jarque Ramos, I.; Solano Vercet, C.; Cherif, H.; Ljungman, P.; Vaht, K.; Cook, G.; Kanfer, E.; Milligan, D.W.; Parker, A.; Akard, L.; Bachier, C.; Ball, E.D.; Betts, F.R.; Braunschweig, I.; Brown, J.M.; Carroll, M.P.; Chandrasekar, P.H.; Collins, R.; Cooper, B.; Craig, M.; D'Cunha, N.; Donato, M.L.; Essell, J.; Flomenberg, P.; Freifeld, A.; Freytes, C.; Guarino, M.J.; Hall, M.C.; Heimenz, J.W.; High, K.P.; Isola, L.M.; Kaminer, L.; Klein, L.M.; Janakiraman, N.; Kane, K.; Komanduri, K.; Krijanovski, O.I.; Lawrence, S.J.; Leis, J.F.; Lill, M.; Longo, W.L.; Lynch, J.P.; Mattar, B.I.; Mehta, J.; Mullane, K.M.; Nathan, S.; Papanicolaou, G.A.; Pergam, S.A.; Roy, V.; Rybka, W.; Safah, H.; Saltzman, D.; Segal, G.M.; Selby, G.B.; Schuster, M.W.; Shoham, S.; Sloan, J.M.; Strasfeld, L.M.; Styler, M.; Sullivan, K.; Tse, W.; Vance, E.A.; Winston, D.J.; Yanovich, S. (2018). Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. THE LANCET, vol. 391, pp. 2116-2127, ISSN:0140-6736 DOI Accesso ONLINE all'editore

Pierelli L.; Bosi A.; Olivieri A. (2018). “Best practice” for extracorporeal photopheresis in acute and chronic graft-versus-host disease by Societa’ Italiana di Emaferesi and Manipolazione Cellulare and Gruppo Italiano Trapianto Midollo Osseo: a national survey to ascertain its degree of application in Italian transplant centers. TRANSFUSION, vol. 58, pp. 217-222, ISSN:0041-1132 DOI

Bocchia, Monica*; Sicuranza, Anna; Abruzzese, Elisabetta; Iurlo, Alessandra; Sirianni, Santina; Gozzini, Antonella; Galimberti, Sara; Aprile, Lara; Martino, Bruno; Pregno, Patrizia; Sorà, Federica; Alunni, Giulia; Fava, Carmen; Castagnetti, Fausto; Puccetti, Luca; Breccia, Massimo; Cattaneo, Daniele; Defina, Marzia; Mulas, Olga; Baratè, Claudia; Caocci, Giovanni; Sica, Simona; Gozzetti, Alessandro; Luciano, Luigiana; Crugnola, Monica; Annunziata, Mario; Tiribelli, Mario; Pacelli, Paola; Ferrigno, Ilaria; Usala, Emilio; Sgherza, Nicola; Rosti, Gianantonio; Bosi, Alberto; Raspadori, Donatella (2018). Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission. FRONTIERS IN ONCOLOGY, vol. 8, pp. 194-198, ISSN:2234-943X DOI Accesso ONLINE all'editore

Cencini, Emanuele; Fabbri, Alberto; Rigacci, Luigi; Lazzi, Stefano; Gini, Guido; Cox, Maria Christina; Mancuso, Salvatrice; Abruzzese, Elisabetta; Kovalchuk, Sofia; Goteri, Gaia; Di Napoli, Arianna; Bono, Roberto; Fratoni, Stefano; Di Lollo, Simonetta; Bosi, Alberto; Leoncini, Lorenzo; Bocchia, Monica (2017). Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment. HEMATOLOGICAL ONCOLOGY, vol. 35, pp. 69-78, ISSN:0278-0232 DOI Accesso ONLINE all'editore

Mannelli, F; Ponziani, V; Bencini, S; Bonetti, Mi; Benelli, M; Cutini, I; Gianfaldoni, G; Scappini, B; Pancani, F; Piccini, M; Rondelli, T; Caporale, R; Gelli, Am; Peruzzi, B; Chiarini, M; Borlenghi, E; Spinelli, O; Giupponi, D; Zanghì, P; Bassan, R; Rambaldi, A; Rossi, G; Bosi, A (2017). CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features.. HAEMATOLOGICA, pp. 529-540, ISSN:1592-8721 DOI

Todisco, E; Ciceri, F; Boschini, C; Giglio, F; Bacigalupo, A; Patriarca, F; Donnini, I; Alessandrino, Ep; Arcese, W; Iori, Ap; Marenco, P; Cavattoni, I; Chiusolo, P; Terruzzi, E; Castagna, L; Santoro, A; Bosi, A; Oldani, E; Bruno, B; Bonifazi, F; Rambaldi, A. (2017). Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO).. BONE MARROW TRANSPLANTATION, pp. 300-304, ISSN:1476-5365

Lanza, F; Saraceni, F; Pezzi, A; Martino, M; Bosi, A; Cascavilla, N; Musto, P; Zuffa, E; Tani, M; Cellini, C; Laszlo, D; Bonifazi, F (2017). A comparative analysis of biosimilar vs originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma; a propensity-score weighted multicenter approach. AMERICAN JOURNAL OF HEMATOLOGY, pp. 300-312, ISSN:0361-8609 DOI

Prince, H Miles; Kim, Youn H; Horwitz, Steven M; Dummer, Reinhard; Scarisbrick, Julia; Quaglino, Pietro; Zinzani, Pier Luigi; Wolter, Pascal; Sanches, Jose A; Ortiz-Romero, Pablo L; Akilov, Oleg E; Geskin, Larisa; Trotman, Judith; Taylor, Kerry; Dalle, Stephane; Weichenthal, Michael; Walewski, Jan; Fisher, David; Dréno, Brigitte; Stadler, Rudolf; Feldman, Tatyana; Kuzel, Timothy M; Wang, Yinghui; Palanca-Wessels, Maria Corinna; Zagadailov, Erin; Trepicchio, William L; Zhang, Wenwen; Lin, Hui-Min; Liu, Yi; Huebner, Dirk; Little, Meredith; Whittaker, Sean; Duvic, Madeleine; Bosi, A (2017). Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. THE LANCET, pp. 266-267, ISSN:0140-6736 DOI

Fogli, Silvia; Montis, Costanza; Paccosi, Sara; Silvano, Angela; Michelucci, Elena; Berti, Debora; Bosi, Alberto; Parenti, Astrid; Romagnoli, Paolo (2017). Inorganic nanoparticles as potential regulators of immune response in dendritic cells. NANOMEDICINE, pp. 61-67, ISSN:1743-5889 DOI

Rigacci, L; Perrone, G; Nobili, S; Kovalchuk, S; Puccini, B; Tassi, R; Brugia, M; Landini, I; Mannelli, L; Benelli, G; Napoli, C; Cencini, E; Fabbri, A; Iovino, L; Petrini, M; Birtolo, S; Melosi, A; Santini, S; Bernardeschi, P; Bosi, A; Mini, E (2017). Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study.. HEMATOLOGICAL ONCOLOGY, vol. 35, pp. 291-292, ISSN:1099-1069 DOI

Cencini, Emanuele; Puccini, Benedetta; Rigacci, Luigi; Fabbri, Alberto; Kovalchuk, Sofia; Mannelli, Lara; Benelli, Gemma; Carfagno, Tommaso; Simontacchi, Gabriele; Bocchia, Monica; Bosi, Alberto (2017). Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma. LEUKEMIA & LYMPHOMA, pp. 1-7-7, ISSN:1042-8194 DOI

Baron, Frédéric; Ruggeri, Annalisa; Beohou, Eric; Labopin, Myriam; Mohty, Mohamad; Sanz, Jaime; Vigouroux, Stephane; Furst, Sabine; Bosi, Alberto; Chevallier, Patrice; Cornelissen, Jan J; Michallet, Mauricette; Sierra, Jorge; Karakasis, Dimitrios; Savani, Bipin N; Gluckman, Eliane; Nagler, Arnon (2017). Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukemia: a report from Eurocord and the ALWP of the EBMT. JOURNAL OF INTERNAL MEDICINE, pp. 413-417, ISSN:0954-6820 DOI

Spadaro, Giuseppe; Vultaggio, Alessandra; Bosi, Alberto; Reichert, Dietmar; Janssen, Jan; Lamacchia, Donatella; Nappi, Liliana; Pecoraro, Antonio; Milito, Cinzia; Ferraro, Andrea; Matucci, Andrea; Bacchiarri, Francesca; Carrai, Valentina; Hibbeler, Azra; Speckman, Elisabet; Guarnieri, Chiara; Bongiovanni, Serena; Quinti, Isabella (2017). Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42]. INTERNATIONAL IMMUNOPHARMACOLOGY, pp. 100-105, ISSN:1567-5769 DOI Accesso ONLINE all'editore

Galimberti, Sara; Ciabatti, Elena; Ercolano, Giacomo; Grassi, Susanna; Guerrini, Francesca; Cecconi, Nadia; Rousseau, Martina; Cervetti, Giulia; Mazziotta, Francesco; Iovino, Lorenzo; Falzetti, Franca; Falcinelli, Flavio; Bosi, Alberto; Rigacci, Luigi; Kovalchuk, Sofia; Vallisa, Daniele; Macchia, Lucia; Ciancia, Eugenio; Petrini, Mario (2017). The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study. FRONTIERS IN PHARMACOLOGY, vol. 8, pp. 25-30, ISSN:1663-9812 DOI Accesso ONLINE all'editore

Galimberti, Sara; Bucelli, Cristina; Arrigoni, Elena; Baratã, Claudia; Grassi, Susanna; Ricci, Federica; Guerrini, Francesca; Ciabatti, Elena; Fava, Carmen; D'Avolio, Antonio; Fontanelli, Giulia; Cambrin, Giovanna Rege; Isidori, Alessandro; Loscocco, Federica; Caocci, Giovanni; Greco, Marianna; Bocchia, Monica; Aprile, Lara; Gozzini, Antonella; Scappini, Barbara; Cattaneo, Daniele; Scortechini, Anna Rita; Nasa, Giorgio La; Bosi, Alberto; Leoni, Pietro; Danesi, Romano; Saglio, Giuseppe; Visani, Giuseppe; Cortelezzi, Agostino; Petrini, Mario; Lurlo, Alessandra; Di Paolo, Antonello (2017). The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia. ONCOTARGET, vol. 8, pp. 88021-88033, ISSN:1949-2553 DOI Accesso ONLINE all'editore

Della Porta, M. G; Jackson, C. H; Alessandrino, E. P; Rossi, M; Bacigalupo, A; van Lint, M. T; Bernardi, M; Allione, B; Bosi, Alberto; Guidi, S; Santini, Valeria; Malcovati, L; Ubezio, M; Milanesi, C; Todisco, E; Voso, M. T; Musto, P; Onida, F; Iori, A. P; Cerretti, R; Grillo, G; Molteni, A; Pioltelli, P; Borin, L; Angelucci, E; Oldani, E; Sica, S; Pascutto, C; Ferretti, V; Santoro, A; Bonifazi, F; Cazzola, M; Rambaldi, A. (2017). Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised international prognostic scoring system (IPSS-R). LEUKEMIA, pp. 22-29, ISSN:0887-6924 DOI

L. Rigacci; G. Perrone; S. Nobili; S. Kovalchuk; B. Puccini; R. Tassi; M. Brugia; I. Landini; L. Mannelli; G. Benelli; C. Napoli; E. Cencini; A. Fabbri; L. Iovino; M. Petrini; S. Birtolo; A. Melosi; S. Santini; P. Bernardeschi; A. Bosi; E. Mini (2017). Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study.. HAEMATOLOGICA, vol. 102, pp. 574-574, ISSN:0390-6078

Dodero, A; Patriarca, F; Milone, G; Sarina, B; Miceli, R; Iori, A; Barretta, F; Terruzzi, E; Mussetti, A; Pini, M; Bosi, A; Dominietto, A; Cascavilla, N; Onida, F; Narni, F; Farina, L; Rambaldi, A; Corradini, P. (2017). Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen.. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 1083-8791(17)30382-8, pp. 382-388, ISSN:1083-8791 DOI

Coltro, Giacomo; Mannelli, Francesco; Guglielmelli, Paola; Pacilli, Annalisa; Bosi, Alberto; Vannucchi, Alessandro Maria (2017). A life-threatening ruxolitinib discontinuation syndrome. AMERICAN JOURNAL OF HEMATOLOGY, pp. 24775-24776, ISSN:0361-8609 DOI

Rosti, Giovanni; Petrini, Mario; Bosi, Alberto; Galieni, Piero; Bernardi, Daniele; Giglio, Gianfranco; Dorotea, Laura; Falini, Brunangelo; Scelzi, Elvira; Veltri, Enzo; Castelli, Roberto; Longagnani, Chiara; Raggi, Tommaso; Simonetti, Federico (2017). Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: Results of an Italian observational, retrospective study. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, vol. 9, pp. 22-32, ISSN:1758-8340 DOI Accesso ONLINE all'editore

Spadaro, G; Vultaggio, A; Bosi, Alberto; Reichert, D; Janssen, J; Lamacchia, D; Nappi, L; Pecoraro, A; Milito, C; Ferraro, A; Matucci, Andrea; Bacchiarri, Francesca; Carrai, V; Hibbeler, A; Speckman, E; Guarnieri, C; Bongiovanni, S; Quinti, I. (2017). Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia.. INTERNATIONAL IMMUNOPHARMACOLOGY, pp. 38-42, ISSN:1567-5769 DOI

S Kovalchuk, L Rigacci, G Perrone, S Nobili, B Puccini, R Tassi, M Brugia, I Landini, L Mannelli, G Benelli, C Napoli, E Cencini, A Fabbri, L Iovino, M Petrini, S Birtolo, A Melosi, S Santini, P Bernardeschi, A Bosi, E Mini (2017). THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY. HAEMATOLOGICA, vol. 102, pp. 27-27, ISSN:0390-6078

Jakubowiak, Andrzej; Offidani, Massimo; Pégourie, Brigitte; De La Rubia, Javier; Garderet, Laurent; Laribi, Kamel; Bosi, Alberto; Marasca, Roberto; Laubach, Jacob; Mohrbacher, Ann; Carella, Angelo Michele; Singhal, Anil K.; Tsao, L. Claire; Lynch, Mark; Bleickardt, Eric; Jou, Ying Ming; Robbins, Michael; Palumbo, Antonio (2016). Randomized phase 2 study: Elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM. BLOOD, vol. 127, pp. 2833-2840, ISSN:0006-4971 DOI Accesso ONLINE all'editore

Engelhardt, M; Repp, R; Teichmann, M; Fenk, R; Munder, M; Langer, C; Jung, W; Binder, M; Bassermann, F; Weisel, K; Vohringer, M; Knop, S; Schmidt-Hieber, M; Altai, E; Nagy, Z; Szomor, A; Gasztonyi, Z; Illes, A; Masszi, T; Carella, Am; Palumbo, A; Foa, R; Musto, P; Cavo, M; Corradini, P; Di Raimondo, F; Bosi, A; Corso, A; Ferrara, F; Cascavilla, N; Rambaldi, A (2016). Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.. THE NEW ENGLAND JOURNAL OF MEDICINE, pp. 754-766, ISSN:0028-4793 DOI

Caldini, Anna; Nozzoli, Chiara; Terreni, Alessandro; Staderini, Michela; Berardi, Margherita; Biagioli, Tiziana; Brogi, Marco; Bosi, Alberto (2016). New patterns of relapse in multiple myeloma: A case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, vol. 54, pp. 991-995, ISSN:1434-6621 DOI Accesso ONLINE all'editore

Czerw, Tomasz; Labopin, Myriam; Gorin, Norbert-Claude; Giebel, Sebastian; Blaise, Didier; Meloni, Giovanna; Pigneux, Arnaud; Bosi, Alberto; Veelken, Joan; Ferrara, Felicetto; Schaap, Nicolaas; Lemoli, Roberto M.; Cornelissen, Jan J.; Beohou, Eric; Nagler, Arnon; Mohty, Mohamad (2016). Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. CANCER, vol. 122, pp. 1880-1887, ISSN:0008-543X DOI Accesso ONLINE all'editore

Bocchia, M; Galimberti, S; Aprile, L; Sicuranza, A; Gozzini, A; Santilli, F; Abruzzese, E; Baratè, C; Scappini, B; Fontanelli, G; Trawinska, Mm; Defina, M; Gozzetti, A; Bosi, A; Petrini, M; Puccetti, L (2016). Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients.. ONCOTARGET, pp. 10-20, ISSN:1949-2553

Saraceni, F; Bruno, B; Lemoli, Rm; Meloni, G; Arcese, W; Falda, M; Ciceri, F; Alessandrino, Ep; Specchia, G; Scimè, R; Raimondi, R; Bacigalupo, A; Bosi, A; Onida, F; Rambaldi, A; Bonifazi, F; Olivieri, A (2016). Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.. BONE MARROW TRANSPLANTATION, pp. 26-30, ISSN:1476-5365

Mazzoccoli, Gianluigi; Miscio, Giuseppe; Fontana, Andrea; Copetti, Massimiliano; Francavilla, Massimo; Bosi, Alberto; Perfetto, Federico; Valoriani, Alice; De Cata, Angelo; Santodirocco, Michele; Totaro, Angela; Rubino, Rosa; Di Mauro, Lazzaro; Tarquini, Roberto (2016). Time related variations in stem cell harvesting of umbilical cord blood. SCIENTIFIC REPORTS, vol. 6, pp. 21404-21414, ISSN:2045-2322 DOI Accesso ONLINE all'editore

Martino, Massimo; Lanza, Francesco; Pavesi, Lorenzo; Öztürk, Mustafa; Blaise, Didier; Leno Núñez, Rubén; Schouten, Harry C; Bosi, Alberto; De Giorgi, Ugo; Generali, Daniele; Rosti, Giovanni; Necchi, Andrea; Ravelli, Andrea; Bengala, Carmelo; Badoglio, Manuela; Pedrazzoli, Paolo; Bregni, Marco (2016). High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 22, pp. 475-81-481, ISSN:1083-8791 DOI

Della Porta, Mg; Gallì, A; Bacigalupo, A; Zibellini, S; Bernardi, M; Rizzo, E; Allione, B; van Lint, Mt; Pioltelli, P; Marenco, P; Bosi, A (2016). Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.. JOURNAL OF CLINICAL ONCOLOGY, pp. 18-26, ISSN:0732-183X

Scholkmann, Felix; Miscio, Giuseppe; Tarquini, Roberto; Bosi, Alberto; Rubino, Rosa; di Mauro, Lazzaro; Mazzoccoli, Gianluigi (2016). The circadecadal rhythm of oscillation of umbilical cord blood parameters correlates with geomagnetic activity - An analysis of long-term measurements (1999-2011). CHRONOBIOLOGY INTERNATIONAL, pp. 1-12-12, ISSN:0742-0528 DOI

Moreau, P; Masszi, T; Grzasko, N; Bahlis, Nj; Hansson, M; Pour, L; Sandhu, I; Ganly, P; Baker, Bw; Jackson, Sr; Stoppa, Am; Simpson, Dr; Gimsing, P; Palumbo, A; Garderet, L; Cavo, M; Kumar, S; Touzeau, C; Buadi, Fk; Laubach, Jp; Berg, Dt; Lin, J; Di Bacco, A; Hui, Am; van de Velde, H; Richardson, Pg; Braester, A; Avivi, I; Benyamini, N; Hardan, I; Nagler, A; Shvetz, O; Trestman, S; Magen Nativ, H; Aversa, F; Bosi, Alberto (2016). Oral Ixazomib, lenalidomide, and dexamethasone for multiple myeloma. THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 374, pp. 1621-1634, ISSN:0028-4793 DOI Accesso ONLINE all'editore

Malagola, M; Cancelli, V; Skert, C; Leali, Pf; Ferrari, E; Tiburzi, A; Sala, Ml; Donnini, I; Chiusolo, P; Muffetti, A; Battista, M; Turra, A; Cattina, F; Rambaldi, B; Schieppati, F; Polverelli, N; Bernardi, S; Perucca, S; Marini, M; Laszlo, D; Savignano, C; Patriarca, F; Corradini, P; Piccirillo, N; Sica, S; Bosi, A; Russo, D. (2016). EXTRACORPOREAL PHOTOPHERESIS (ECP) FOR TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: AN ITALIAN MULTICENTRIC RETROSPECTIVE ANALYSIS ON 94 PATIENTS ON BEHALF OF THE GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO (GITMO).. TRANSPLANTATION, pp. 0-0, ISSN:0041-1337

Rambaldi, Alessandro; Grassi, Anna; Masciulli, Arianna; Boschini, Cristina; Micò, Maria Caterina; Busca, Alessandro; Bruno, Benedetto; Cavattoni, Irene; Santarone, Stella; Raimondi, Roberto; Montanari, Mauro; Milone, Giuseppe; Chiusolo, Patrizia; Pastore, Domenico; Guidi, Stefano; Patriarca, Francesca; Risitano, Antonio M.; Saporiti, Giorgia; Pini, Massimo; Terruzzi, Elisabetta; Arcese, William; Marotta, Giuseppe; Carella, Angelo Michele; Nagler, Arnon; Russo, Domenico; Corradini, Paolo; Alessandrino, Emilio Paolo; Torelli, Giovanni Fernando; Scimè, Rosanna; Mordini, Nicola; Oldani, Elena; Marfisi, Rosa Maria; Bacigalupo, Andrea; Bosi, Alberto (2015). Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial. THE LANCET ONCOLOGY, vol. 16, pp. 1525-1536, ISSN:1470-2045 DOI Accesso ONLINE all'editore

Castagnetti, Fausto; Gugliotta, G.; Baccarani, M.; Breccia, M.; Specchia, G.; Levato, L.; Abruzzese, E.; Rossi, G.; Iurlo, A.; Martino, B.; Pregno, P.; Stagno, F.; Cuneo, A.; Bonifacio, M.; Gobbi, M.; Russo, D.; Gozzini, A.; Tiribelli, M.; De Vivo, A.; Alimena, G.; Cavo, M.; Martinelli, G.; Pane, F.; Saglio, G.; Rosti, G.; Salvi, F.; Pini, M.; Leoni, P.; Rupoli, S.; Galieni, P.; Bigazzi, C.; Cantore, N.; Palmieri, F.; Albano, F.; Russo Rossi, A.; Rambaldi, A.; Intermesoli, T.; Palandri, F.; Testoni, N.; Luatti, S.; Soverini, S.; Iacobucci, I.; Bochicchio, M.T.; Apolinari, M.; Fogli, M.; Cervello, I.; Capucci, A.; Malagola, M.; Malpignano, A.; Girasoli, M.; Angelucci, E.; Usala, E.; Storti, S.; De Biasi, E.; Tagariello, G.; Sartori, R.; Di Raimondo, F.; Vigneri, P.; Impera, S.; Molica, S.; Lanza, F.; Viganò, C.; Grasso, M.; Rapezzi, D.; Cavazzini, F.; Bosi, A.; Santini, V.; Capalbo, S.F.; Spinosa, G.; Pierri, I.; Bergamaschi, M.; Carella, A.M.; Bacigalupo, A.; De Blasio, A.; Ciccone, F.; Di Renzo, N.; Musolino, C.; Russo, S.; Cortelezzi, A.; Morra, E.; Pungolino, E.M.; Luppi, M.; Marasca, R.; Pogliani, E.M.; Gambacorti-Passerini, C.; Luciano, L.; Ferrara, F.; Annunziata, M.; Latte, G.; Noli, D.; Rege-Cambrin, G.; Fava, C.; Semenzato, G.; Binotto, G.; Fabbiano, F.; Turri, D.; Siragusa, S.; Caracciolo, C.; Musso, M.; Porretto, F.; Aversa, F.; Crugnola, M.; Cazzola, M.; Orlandi, E.; Falini, B.; Falzetti, F.; Visani, G.; Isidori, A.; Fioritoni, G.; Di Lorenzo, R.; Vallisa, D.; Trabacchi, E.; Petrini, M.; Galimberti, S.; Pizzuti, M.; Zaccaria, A.; Salvucci, M.; Ronco, F.; Ielo, D.; Merli, F.; Avanzini, P.; Tosi, P.; Merli, A.; Musto, P.; De Stefano, V.; Sica, S.; Latagliata, R.; De Fabritiis, P.; Trawiska, M.; Majolino, I.; Pacilli, L.; Ronci, B.; Cedrone, M.; Petti, M.C.; Pisani, F.; Tafuri, A.; Montefusco, E.; Iuliano, F.; Dore, F.; Pardini, S.; Bocchia, M.; Defina, M.; Liberati, A.M.; Luzzi, D.; Boccadoro, M.; Ferrero, D.; Vitolo, U.; Gherlinzoni, F.; Calistri, E.; Fanin, R.; Pizzolo, G.; Meneghini, V.; Rodighiero, F.; D'Emilio, A. (2015). Differences among young adults, adults and elderly chronic myeloid leukemia patients. ANNALS OF ONCOLOGY, vol. 26, pp. 185-192, ISSN:0923-7534 DOI Accesso ONLINE all'editore

Mannelli, Francesco; Ponziani, Vanessa; Bonetti, Maria Ida; Bencini, Sara; Cutini, Ilaria; Gianfaldoni, Giacomo; Scappini, Barbara; Pancani, Fabiana; Rondelli, Tommaso; Benelli, Matteo; Caporale, Roberto; Grazia Gelli, Anna Maria; Peruzzi, Benedetta; Longo, Giovanni; Bosi, Alberto (2015). Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia. EXPERIMENTAL HEMATOLOGY, vol. 43, pp. 869-879, ISSN:0301-472X DOI Accesso ONLINE all'editore

Nozzoli, Chiara; Staderini, Michela; Veltroni, Alessio; Longo, Giovanni; Bacchiarri, Francesca; Donnini, Irene; Guarrera, Agata; Bosi, Alberto (2015). Impact of disease status on outcome in relapsed and refractory multiple myeloma treated with lenalidomide. LEUKEMIA & LYMPHOMA, vol. 56, pp. 2388-2391, ISSN:1042-8194 DOI

Iacobelli, S; De Wreede, L.C.; Schönland, S.; Björkstrand, B.; Hegenbart, U.; Gruber, A.; Greinix, H.; Volin, L.; Narni, F.; Carella, A.M.; Beksac, M.; Bosi, A.; Milone, G.; Corradini, P.; Friberg, K.; Van Biezen, A.; Goldschmidt, H.; De Witte, T.; Morris, C.; Niederwieser, D.; Garderet, L.; Kröger, N.; Gahrton, G. (2015). Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: Results from the EBMT NMAM2000 prospective trial. BONE MARROW TRANSPLANTATION, vol. 50, pp. 505-510, ISSN:0268-3369 DOI Accesso ONLINE all'editore

Rigacci, Luigi; Puccini, Benedetta; Zinzani, Pier Luigi; Biggi, Alberto; Castagnoli, Antonio; Merli, Francesco; Balzarotti, Monica; Stelitano, Caterina; Spina, Michele; Vitolo, Umberto; Stefoni, Vittorio; Levis, Alessandro; Gotti, Manuel; Rosaria, Sancetta; Maria, Stefani Piero; Bosi, Alberto; Gallamini, Andrea (2015). The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL). AMERICAN JOURNAL OF HEMATOLOGY, vol. 90, pp. 499-503, ISSN:0361-8609 DOI Accesso ONLINE all'editore

Ruggeri, A.; Labopin, M.; Sanz, G.; Piemontese, S.; Arcese, W.; Bacigalupo, A.; Blaise, D.; Bosi, A.; Huang, H.; Karakasis, D.; Koc, Y.; Michallet, M.; Picardi, A.; Sanz, J.; Santarone, S.; Sengelov, H.; Sierra, J.; Vincent, L.; Volt, F.; Nagler, A.; Gluckman, E.; Ciceri, F.; Rocha, V.; Mohty, M. (2015). Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. LEUKEMIA, vol. 29, pp. 1891-1900, ISSN:0887-6924 DOI Accesso ONLINE all'editore

Girmenia, C; Rossolini, Gm; Piciocchi, A; Bertaina, A; Pisapia, G; Pastore, D; Sica, S; Severino, A; Cudillo, L; Ciceri, F; Scimè, R; Lombardini, L; Viscoli, C; Rambaldi, A; Bosi, A (2015). Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy. BONE MARROW TRANSPLANTATION, vol. 50, pp. 282-288, ISSN:0268-3369 DOI Accesso ONLINE all'editore

Caldini, A; Nozzoli, C; Terreni, A; Staderini, M; Berardi, M; Biagioli, T; Brogi, M; Bosi, A. (2015). Caldini A, Nozzoli C, Terreni A, Staderini M, Berardi M, Biagioli T, Brogi M, Bosi. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, pp. 991-995, ISSN:1434-6621

Castagnetti, F; Gugliotta, G; Breccia, M; Stagno, F; Iurlo, A; Albano, F; Abruzzese, E; Martino, B; Levato, L; Intermesoli, T; Pregno, P; Rossi, G; Gherlinzoni, F; Leoni, P; Cavazzini, F; Venturi, C; Soverini, S; Testoni, N; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Bosi, A; Gozzini, A (2015). Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib. LEUKEMIA, vol. 29, pp. 1823-1831, ISSN:0887-6924 DOI Accesso ONLINE all'editore

Caldini, A; Nozzoli, C; Terreni, A; Staderini, M; Berardi, M; Biagioli, T; Brogi, M; Bosi, A. (2015). New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, pp. 1-10, ISSN:1434-6621

Pennucci, V1; Zini, R; Norfo, R; Guglielmelli, Paola; Bianchi, E; Salati, S; Sacchi, G; Prudente, Z; Tenedini, E; Ruberti, S; Paoli, C; Fanelli, Tiziana; Mannarelli, C; Tagliafico, E; Ferrari, S; Vannucchi, Am; Manfredini, R; Bogani, C; Bosi, Alberto; Fanelli, T; Fjerza, Rajmonda; Guglielmelli, P. (2015). Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations.. LEUKEMIA & LYMPHOMA, pp. 492-496, ISSN:1042-8194

Spina, Michele; Nagy, Z.; Ribera, J. M.; Federico, M.; Aurer, I.; Jordan, K.; Borsaru, G.; Pristupa, A. S.; Bosi, Alberto; Grosicki, S.; Glushko, N. L.; Ristic, D.; Jakucs, J.; Montesinos, P.; Mayer, J.; Rego, E. M.; Baldini, S.; Scartoni, S.; Capriati, A.; Maggi, C. A.; Simonelli, C. (2015). FLORENCE: A randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. ANNALS OF ONCOLOGY, vol. 26, pp. 2155-2161, ISSN:0923-7534 DOI Accesso ONLINE all'editore

Baron, Frédéric; Labopin, Myriam; Ruggeri, Annalisa; Mohty, Mohamad; Sanz, Guillermo; Milpied, Noel; Bacigalupo, Andrea; Rambaldi, Alessandro; Bonifazi, Francesca; Bosi, Alberto; Sierra, Jorge; Yakoub Agha, Ibrahim; Santasusana, Josep Maria Ribera; Gluckman, Eliane; Nagler, Arnon (2015). Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: Higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood-a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation. JOURNAL OF HEMATOLOGY & ONCOLOGY, vol. 8, pp. 107-118, ISSN:1756-8722 DOI Accesso ONLINE all'editore

Rigacci, L; Perrone, G; Nobili, S; Kovalchuk, S; Puccini, B; Lancia, F; Tassi, R; Brugia, M; Landini, I; Mannelli, L; Benelli, G; Napoli, C; Cencini, E; Fabbri, A; Iovino, L; Petrini, M; Birtolo, S; Melosi, A; Martini, V; Santini, S; Breschi, C; Bernardeschi, P; Bengala, C; Bosi, A; Mini, E (2015). Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study. BLOOD, vol. 126, pp. 2483-2483, ISSN:1528-0020

Andreola, G.; Labopin, M.; Beelen, D.; Chevallier, P.; Tabrizi, R.; Bosi, A.; Michallet, M.; Santarone, S.; Ehninger, G.; Polge, E.; Laszlo, D.; Schmid, C.; Nagler, A.; Mohty, M. (2015). Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ≥10 years. BONE MARROW TRANSPLANTATION, vol. 50, pp. 1508-1512, ISSN:0268-3369 DOI Accesso ONLINE all'editore

Vannucchi AM;Rotunno G;Bartalucci N;Raugei G;Carrai V;Balliu M;Mannarelli C;Pacilli A;Calabresi L;Fjerza R;Pieri L;Bosi A;Manfredini R;Guglielmelli P (2014). Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value.. LEUKEMIA, vol. 28, pp. 1811-1818, ISSN:0887-6924 DOI

Francesco Mannelli, Ilaria Cutini, Giacomo Gianfaldoni, Sara Bencini, Barbara Scappini, Fabiana Pancani, Vanessa Ponziani, Maria Ida Bonetti, Caterina Biagiotti, Giovanni Longo, Alberto Bosi (2014). CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.. CYTOMETRY. PART B, CLINICAL CYTOMETRY, pp. 340-349, ISSN:1552-4949 DOI

Girmenia, Corrado; Raiola, Anna Maria; Piciocchi, Alfonso; Algarotti, Alessandra; Stanzani, Marta; Cudillo, Laura; Pecoraro, Clara; Guidi, Stefano; Iori, Anna Paola; Montante, Barbara; Chiusolo, Patrizia; Lanino, Edoardo; Carella, Angelo Michele; Zucchetti, Elisa; Bruno, Benedetto; Irrera, Giuseppe; Patriarca, Francesca; Baronciani, Donatella; Musso, Maurizio; Prete, Arcangelo; Risitano, Antonio Maria; Russo, Domenico; Mordini, Nicola; Pastore, Domenico; Vacca, Adriana; Onida, Francesco; Falcioni, Sadia; Pisapia, Giovanni; Milone, Giuseppe; Vallisa, Daniele; Olivieri, Attilio; Bonini, Alessandro; Castagnola, Elio; Sica, Simona; Majolino, Ignazio; Bosi, Alberto; Busca, Alessandro; Arcese, William; Bandini, Giuseppe; Bacigalupo, Andrea; Rambaldi, Alessandro; Locasciulli, Anna (2014). Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: A prospective study of the gruppo italiano trapianto midollo osseo (GITMO). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 20, pp. 872-880, ISSN:1083-8791 DOI

Vannucchi, A.M.; Rotunno, G.; Bartalucci, N.; Raugei, G.; Carrai, V.; Balliu, M.; Mannarelli, C.; Pacilli, A.; Calabresi, L.; Fjerza, R.; Pieri, L.; Bosi, A.; Manfredini, R.; Guglielmelli, P. (2014). Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value. LEUKEMIA, vol. 28, pp. 1811-1818, ISSN:0887-6924 DOI Accesso ONLINE all'editore

Baldini, S; Carrai, V.; Puccini, B.; Rigacci, L.; Alterini, R.; Bosi, A. (2014). Romiplostim before splenectomy in a patient with aggressive non-Hodgkin lymphoma and poor response to platelet transfusions. TRANSFUSION MEDICINE, vol. 24, pp. 125-126, ISSN:0958-7578 DOI Accesso ONLINE all'editore

Patriarca, Francesca; Luznik, Leo; Medeot, Marta; Zecca, Marco; Bacigalupo, Andrea; Di Bartolomeo, Paolo; Arcese, William; Corradini, Paolo; Ciceri, Fabio; Vago, Luca; Kanakry, Christopher G.; Fleischhauer, Katharina; Martelli, Massimo F.; Bosi, Alberto; Rambaldi, Alessandro; Cesaro, Simone; Russo, Domenico; Fanin, Renato (2014). Experts' considerations on HLA-haploidentical stem cell transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY, vol. 93, pp. 187-197, ISSN:0902-4441 DOI Accesso ONLINE all'editore

Rigacci, Luigi; Puccini, Benedetta; Kovalchuk, Sofia; Fabbri, Elisa; Bonizzoni, Erminio; Perrone, Tania; Bosi, Alberto (2014). Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen. SUPPORTIVE CARE IN CANCER, vol. 22, pp. 2557-2561, ISSN:0941-4355 DOI Accesso ONLINE all'editore

Girmenia, Corrado; Barosi, Giovanni; Piciocchi, Alfonso; Arcese, William; Aversa, Franco; Bacigalupo, Andrea; Bandini, Giuseppe; Bosi, Alberto; Busca, Alessandro; Castagnola, Elio; Caselli, Desiree; Cesaro, Simone; Ciceri, Fabio; Locasciulli, Anna; Locatelli, Franco; Mikulska, Malgorzata; Pagano, Livio; Prete, Arcangelo; Raiola, Anna Maria; Rambaldi, Alessandro (2014). Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 20, pp. 1080-1088, ISSN:1083-8791 DOI Accesso ONLINE all'editore

Della Porta, Matteo G.; Alessandrino, Emilio Paolo; Bacigalupo, Andrea; Van Lint, Maria Teresa; Malcovati, Luca; Pascutto, Cristiana; Falda, Michele; Bernardi, Massimo; Onida, Francesco; Guidi, Stefano; Iori, Anna Paola; Cerretti, Raffaella; Marenco, Paola; Pioltelli, Pietro; Angelucci, Emanuele; Oneto, Rosi; Ripamonti, Francesco; Bernasconi, Paolo; Bosi, Alberto; Cazzola, Mario; Rambaldi, Alessandro (2014). Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. BLOOD, vol. 123, pp. 2333-2342, ISSN:0006-4971 DOI Accesso ONLINE all'editore

Lanza, Francesco; Lemoli, Roberto M.; Olivieri, Attilio; Laszlo, Daniele; Martino, Massimo; Specchia, Giorgina; Pavone, Vincenzo; Imola, Manuela; Pasini, Annalisa; Milone, Giuseppe; Scortechini, Ilaria; Todisco, Elisabetta; Guggiari, Elena; Cascavilla, Nicola; Martinelli, Giovanni; Rambaldi, Alessandro; Bosi, Alberto (2014). Factors affecting successful mobilization with plerixafor: An Italian prospective survey in 215 patients with multiple myeloma and lymphoma. TRANSFUSION, vol. 54, pp. 331-339, ISSN:0041-1132 DOI

Mauro, Francesca R; Molica, Stefano; Laurenti, Luca; Cortelezzi, Agostino; Carella, Angelo M.; Zaja, Francesco; Chiarenza, Annalisa; Angrilli, Francesco; Nobile, Francesco; Marasca, Roberto; Musolino, Caterina; Brugiatelli, Maura; Piciocchi, Alfonso; Vignetti, Marco; Bosi, Alberto (2014). Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile. LEUKEMIA RESEARCH, vol. 38, pp. 198-203, ISSN:0145-2126 DOI

Rotunno G;Mannarelli C;Guglielmelli P;Pacilli A;Pancrazzi A;Pieri L;Fanelli T;Bosi A;Vannucchi AM. (2014). Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia.. BLOOD, vol. 123, pp. 1552-1555, ISSN:0006-4971 DOI

Valencia A; Masala E; Rossi A; Martino A; Sanna A; Buchi F; Canzian F; Cilloni D; Gaidano V; Voso MT; Kosmider O; Fontenay M; Gozzini A; Bosi A; Santini V. (2014). Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine.. LEUKEMIA, vol. 28, pp. 621-628, ISSN:0887-6924 DOI Accesso ONLINE all'editore

Olivieri, Jacopo; Pierelli, Luca; Introna, Martino; Accorsi, Patrizia; Bosi, Alberto; Perseghin, Paolo; Risso, Marco; Pandolfi, Annino; Mancini, Stefania; Marchetti, Monia; Dal Pozzo, Simone; Gotti, Elisa; Rambaldi, Alessandro; Leoni, Pietro; Olivieri, Attilio (2014). Kinetics of the use of cryopreserved autologous stem cell grafts: A GITMO-SIDEM survey. CYTOTHERAPY, vol. 16, pp. 101-110, ISSN:1465-3249 DOI

Perseghin, Paolo; Marchetti, Monia; Pierelli, Luca; Olivieri, Attilio; Introna, Martino; Lombardini, Letizia; Accorsi, Patrizia; Petrini, Carlo; Risso, Marco; Bosi, Alberto (2014). A policy for the disposal of autologous hematopoietic progenitor cells: Report from an Italian consensus panel. TRANSFUSION, vol. 54, pp. 2353-2360, ISSN:0041-1132 DOI Accesso ONLINE all'editore

Fabbri, Alberto; Cencini, Emanuele; Alterini, Renato; Rubegni, Pietro; Rigacci, Luigi; Delfino, Chiara; Puccini, Benedetta; Fimiani, Michele; Bosi, Alberto; Bocchia, Monica; Pimpinelli, Nicola (2014). Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas. EUROPEAN JOURNAL OF HAEMATOLOGY, vol. 93, pp. 129-136, ISSN:0902-4441 DOI Accesso ONLINE all'editore

VALENCIA MARTINEZ, ANA BELEN; Masala, Erico; Rossi, A.; Martino, A.; Sanna, A.; Buchi, Francesca; Canzian, F.; Cilloni, D.; Gaidano, V.; Voso, M. T.; Kosmider, O.; Fontenay, M.; Gozzini, A.; Bosi, Alberto; Santini, Valeria (2014). Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. LEUKEMIA, vol. 28, pp. 621-628, ISSN:0887-6924 DOI Accesso ONLINE all'editore

Rumi E, Pietra D, Pascutto C, Guglielmelli P, Martínez-Trillos A, Casetti I, Colomer D, Pieri L, Pratcorona M, Rotunno G, Sant'Antonio E, Bellini M, Cavalloni C, Mannarelli C, Milanesi C, Boveri E, Ferretti V, Astori C, Rosti V, Cervantes F, Barosi G, Vannucchi AM, Cazzola M;Bisognin, A; Bogani, C; Bortoluzzi, S; Bosi, A (2014). Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.. BLOOD, pp. 1062-1069, ISSN:0006-4971

Paola Guglielmelli; Giada Rotunno;Giada Brogi;Annalisa Pacilli;Costanza Bogani;Carmela Mannarelli;Alessandro Pancrazzi;Rajmonda Fjerza;Lisa Pieri;Elisa Rumi;Daniela Pietra;Federica Delaini;Silvia Salmoiraghi;Aldesia Provenzano; Laura Giunti;Sabrina Giglio;Margherita Maffioli;Alberto Bosi;Alessandro Rambaldi;Tiziano Barbui; Francesco Passamonti; Mario Cazzola and Alessandro Maria Vannucchi (2014). Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2V617F Mutation: A Study from the AGIMM Group. In: The 56th Annual Meeting of the American Society of Hematology, American Society of Hematology, pp. 3179-3179.

Nobili S; Napoli C; Puccini B; Landini I; Perrone G; Brugia M; Benelli G; Doria M; Martelli M; Finolezzi E; Di Rocco A; Del Fava E; Rigacci L; Di Lollo S; Bosi A; Mini E. (2014). Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma. LEUKEMIA & LYMPHOMA, vol. 55, pp. 2071-2078, ISSN:1042-8194 DOI

Maria Ida Bonetti; Stefano Bacci; Michela Santosuosso; Benedetta Mazzanti; Alessandra Aldinucci; Clara Ballerini; Daniele Guasti; Laura Calosi; Alberto Bosi; Paolo Romagnoli. (2014). Rosiglitazone promotes the differentiation of Langerhans cells and inhibits that of other dendritic cell types from CD133 positive hematopoietic precursors. HISTOLOGY AND HISTOPATHOLOGY, vol. 29, pp. 323-332, ISSN:0213-3911 Accesso ONLINE all'editore

Pieri L, Bonadonnap; Elena, C; Papayannidis, C; Grifoni, Fi; Rondoni, M; Girlanda, S; Mauro, M; Magliacane, D; Elli, Em; Iorno, Ml; Severino, M; Almerigogna, F; Scarfì, F; Bonifacio, M; Perbellini, O; Artuso, A; Soverini, S; De Benedittis, C; Muratori, S; Lunardon, L; Cova, V; Cortellini, G; Bosi, A; Cortelezzi, A; Martinelli, G; Triggiani, M; Merante, S; Vannucchi, Am (2014). A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis.. In: 56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, DEC 06-09, 2014, American Society of Hematology, vol. 124, pp. 3188-3188. DOI Accesso ONLINE all'editore

Gallina P; Paganini M; Lombardini L; Biggeri A; Marini M; Morelli AM; Bucciantini S; Sarchielli E; Ambrosini S; Mechi C; Romoli AM; Ghelli E; Pradella S; Urbani S; Mazzanti B; Berti V; Giordano GP; Campolo M; Dal Pozzo S; Piacentini S; Saccardi R; Massacesi L; Mascalchi M; Bosi A; Conti R; Porfirio B; Di Lorenzo N; Vannelli GB (2014). Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana. TRAPIANTI, vol. 18, pp. 5-11, ISSN:1590-072X

Guglielmelli P;Lasho TL;Rotunno G;Score J;Mannarelli C;Pancrazzi A;Biamonte F;Pardanani A;Zoi K;Reiter A;Duncombe A;Fanelli T;Pietra D;Rumi E;Finke C;Gangat N;Ketterling RP;Knudson RA;Hanson CA;Bosi A;Pereira A;Manfredini R;Cervantes F;Barosi G;Cazzola M;Cross NC;Vannucchi AM;Tefferi A (2014). The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.. LEUKEMIA, vol. 28, pp. 1804-1810, ISSN:0887-6924 DOI

Amedei, Amedeo; Pimpinelli, Nicola; Grassi, Alessia; Bella, Chiara Della; Niccolai, Elena; Brancati, Simona; Benagiano, Marisa; D'Elios, Sofia; Bosi, Alberto; D'Elios, Mario M (2014). Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease. AUTOIMMUNITY HIGHLIGHTS, vol. 5, pp. 21-26, ISSN:2038-0305 DOI Accesso ONLINE all'editore

Fabbri, A; Cencini, E; Rigacci, L; Bartalucci, G; Puccini, B; Dottori, R; Gozzetti, A; Bosi, A; Bocchia, M. (2014). Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas.. LEUKEMIA & LYMPHOMA, pp. 781-785, ISSN:1042-8194

Guglielmelli, P; Rotunno, G; Brogi, G; Pacilli, A; Bogani, C; Mannarelli, C; Pancrazzi, A; Fjerza, R; Pieri, L; Rumi, E; Pietra, D; Salmoiraghi, S; Provenzano, A; Giunti, L; Giglio, S; Maffioli, M; Bosi, A; Rambaldi, A; Barbui, T; Passamonti, F; Cazzola, M; Vannucchi, Am (2014). Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2V617F Mutation: A Study from the AGIMM Group. BLOOD, vol. 124, pp. 3179-3179, ISSN:0006-4971

I. Orsini;F. Orsini;P. Botti;A. Bosi;B. Scappini;F. Bacchiarri;M. D. Gioia;A. Giampreti;G. Mannaioni (2014). Subcutaneous elemental mercury injection and bone marrow failure: A fatal case. CLINICAL TOXICOLOGY, vol. 52, pp. 379-379, ISSN:1556-3650

Bandinelli F;Saccardi R;Salvadorini G;Bosi A;Gozzini A;Matucci Cerinic M (2013). Stiff skin syndrome and myeloma successfully treated with autologous haematopoietic stem cell transplantation (HSCT).. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol. 31, pp. 181-183, ISSN:0392-856X

Peruzzi, Benedetta; Cutini, Ilaria; Gelli, Anna Maria Grazia; Rondelli, Tommaso; Statello, Marinella; Bencini, Sara; Mannelli, Francesco; Caporale, Roberto; Bosi, Alberto; Fanelli, Alessandra (2013). Diagnosis of a T-lineage acute Lymphoblastic leukemia through digitalized cell analysis of the pleural effusion. INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, vol. 6, pp. 77-80, ISSN:1179-142X DOI Accesso ONLINE all'editore

Aprili, Guseppe; Bosi, Alberto; Lombardini, Letizia; Pupella, Simonetta; Vassanelli, Aurora (2013). Recommendations for managing the donation of haematopoietic stem cells from related and unrelated donors for allogeneic transplantation. BLOOD TRANSFUSION, vol. 11, pp. 296-304, ISSN:1723-2007 DOI Accesso ONLINE all'editore

Gahrton, Gösta; Iacobelli, Simona; Björkstrand, B.; Hegenbart, Ute; Gruber, Astrid; Greinix, Hildegard; Volin, Liisa; Narni, Franco; Carella, Angelo Michele; Beksac, Meral; Bosi, Alberto; Milone, Giuseppe; Corradini, Paolo; Schönland, Stefan; Friberg, Kristina; van Biezen, Anja; Goldschmidt, Hartmut; de Witte, Theo; Morris, Curly; Niederwieser, Dietger; Garderet, Laurent; Kröger, Nicolaus; EBMT Chronic Malignancies Working Party Plasma Cell Disorders Subcommittee, Null (2013). Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study. BLOOD, vol. 121, pp. 5055-5063, ISSN:1528-0020 DOI

Alessandrino, Emilio Paolo; Porta, Matteo G. Della; Malcovati, Luca; Jackson, Christopher H; Pascutto, Cristiana; Bacigalupo, Andrea; Teresa van Lint, Maria; Falda, Michele; Bernardi, Massimo; Onida, Francesco; Guidi, Stefano; Iori, Anna Paola; Cerretti, Raffaella; Marenco, Paola; Pioltelli, Pietro; Angelucci, Emanuele; Oneto, Rosi; Ripamonti, Francesco; Rambaldi, Alessandro; Bosi, Alberto; Cazzola, Mario (2013). Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. AMERICAN JOURNAL OF HEMATOLOGY, vol. 88, pp. 581-588, ISSN:0361-8609 DOI

Pierelli, Luca; Perseghin, Paolo; Marchetti, Monia; Messina, Chiara; Perotti, Cesare; Mazzoni, Alessandro; Bacigalupo, Andrea; Locatelli, Franco; Carlier, Paolo; Bosi, Alberto (2013). Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: Best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process. TRANSFUSION, vol. 53, pp. 2340-2352, ISSN:0041-1132 DOI

Todisco, E.; Ciceri, F.; Oldani, E.; Boschini, C.; Micò, C.; Vanlint, M.T.; Donnini, I.; Patriarca, F.; Alessandrino, P.E.; Bonifazi, F.; Arcese, W.; Barberi, W.; Marenco, P.; Terruzzi, E.; Cortelazzo, S.; Santarone, S.; Proia, A.; Corradini, P.; Tagliaferri, E.; Falcioni, S.; Irrera, G.; Dallanegra, L.; Castagna, L.; Santoro, A.; Camboni, A.; Sacchi, N.; Bosi, A.; Bacigalupo, A.; Rambaldi, A. (2013). The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: A retrospective analysis of the Gruppo Italiano Trapianto di Midollo Osseo. LEUKEMIA, vol. 27, pp. 2086-2091, ISSN:0887-6924 DOI

Perseghin, P; Marchetti, M; Messina, C; Mazzoni, A; Carlier, P; Perotti, C; Salvaneschi, L; Risso, M; Fanin, R; Olivieri, A; Accorsi, P; Locatelli, F; Bacigalupo, A; Pierelli, L; Bosi, Alberto (2013). Best practice recommendations in: (1) Peripheral blood stem cell mobilization and collection and (2) acute and chronic GvHD treatment using extracorporeal photopheresis. A joint effort from SIdEM (Società Italiana di Emaferesi e Manipolazione Cellulare) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo). TRANSFUSION AND APHERESIS SCIENCE, vol. 48, pp. 195-6-196, ISSN:1473-0502 DOI

Ladetto, M; Lobetti Bodoni, C; Mantoan, B; Ceccarelli, M; Boccomini, C; Genuardi, E; Chiappella, A; Baldini, L; Rossi, G; Pulsoni, A; Di Raimondo, F; Rigacci, L; Pinto, A; Galimberti, S; Bari, A; Rota Scalabrini, D; Ferrari, A; Zaja, F; Gallamini, A; Specchia, G; Musto, P; Rossi, Fg; Gamba, E; Evangelista, A; Vitolo, U; Raimondo, F; Chiarenza, A; Rigacci, L; Puccini, B; Bosi, Alberto (2013). Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program. BLOOD, vol. 122, pp. 3759-3766, ISSN:0006-4971 DOI Accesso ONLINE all'editore

Valentina Carrai; Irene Donnini; Benedetta Mazzanti; Renato Alterini; Maria Pia Amato; Alessandro Barilaro; Alberto Bosi; Luca Massacesi; Emilio Portaccio; Anna Maria Repice; Giada Rotunno; Riccardo Saccardi. (2013). Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation. CLINICAL NEUROLOGY AND NEUROSURGERY, vol. 115, pp. 1044-1048, ISSN:0303-8467 DOI Accesso ONLINE all'editore

Mazzanti B; Lorenzi B; Lorenzoni P; Borghini A; Boieri M; Lorenzi M; Santosuosso M; Bosi A; Saccardi R; Weber E; Pessina F (2013). Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model.. NEUROGASTROENTEROLOGY & MOTILITY, pp. 669-679, ISSN:1365-2982

Martínez, C; Canals, C.; Sarina, B.; Alessandrino, E.P.; Karakasis, D.; Pulsoni, A.; Sica, S.; Trneny, M.; Snowden, J.A.; Kanfer, E.; Milpied, N.; Bosi, A.; Guidi, S.; De Souza, C.A.; Willemze, R.; Arranz, R.; Jebavy, L.; Hellmann, A.; Sibon, D.; Oneto, R.; Luan, J.J.; Dreger, P.; Castagna, L.; Sureda, A. (2013). Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation. ANNALS OF ONCOLOGY, vol. 24, pp. 2430-2434, ISSN:0923-7534 DOI

Passera, Roberto; Pollichieni, Simona; Brunello, Lucia; Patriarca, Francesca; Bonifazi, Francesca; Montefusco, Vittorio; Falda, Michele; Montanari, Mauro; Guidi, Stefano; Giaccone, Luisa; Mordini, Nicola; Carella, Angelo Michele; Bavaro, Pasqua; Milone, Giuseppe; Benedetti, Fabio; Ciceri, Fabio; Scimè, Rosanna; Benedetti, Edoardo; Castagna, Luca; Festuccia, Moreno; Rambaldi, Alessandro; Bacigalupo, Andrea; Corradini, Paolo; Bosi, Alberto; Boccadoro, Mario; Bandini, Giuseppe; Fanin, Renato; Bruno, Benedetto (2013). Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: Study from the italian bone marrow donor registry. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 19, pp. 940-948, ISSN:1083-8791 DOI

Pierelli, Luca; Berto, Patrizia; Accorsi, Patrizia; Milone, Giuseppe; Lopatriello, Stefania; Aiello, Andrea; Iacopino, Pasquale; Olivieri, Attilio; Rambaldi, Alessandro; Bosi, Alberto (2013). The costs of mobilisation and collection of peripheral blood stem cells in multiple myeloma and lymphoma in an European country: Results from The Gruppo Italiano Trapianto Midollo Osseo (GITMO) and Società Italiana di Emaferesi e Manipolazione Cellulare (SIdEM) survey. TRANSFUSION AND APHERESIS SCIENCE, vol. 49, pp. 615-622, ISSN:1473-0502 DOI

G Milone; G Tripepi; M Martino; F Ancora; B Bartolozzi; A Spadaro; C Nozzoli; A La Fauci; I Amico; S Leotta; M Poidomani; G Irrera; P Iacopino; R Saccardi; S Guidi; A Bosi (2013). Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor. BLOOD TRANSFUSION, vol. 11, pp. 0-0, ISSN:1723-2007 DOI Accesso ONLINE all'editore

Bogani C;Bartalucci N;Martinelli S;Tozzi L;Guglielmelli P;Bosi A;Vannucchi AM. (2013). mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms.. PLOS ONE, vol. 8, pp. e54826-e54826, ISSN:1932-6203 DOI

Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A. (2013). A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.. CYTOMETRY. PART B, CLINICAL CYTOMETRY, vol. 84, pp. 71-81, ISSN:1552-4949 DOI

Scoccianti, G; Rigacci, L; Puccini, B; Campanacci, D; Simontacchi, G; Bosi, A; Capanna, R (2013). Primary lymphoma of bone: Outcome and role of surgery. INTERNATIONAL ORTHOPAEDICS, vol. 37, pp. 2437-2442, ISSN:0341-2695 DOI

Spolverini A;Pieri L;Guglielmelli P;Pancrazzi A;Fanelli T;Paoli C;Bosi A;Nichele I;Ruggeri M;Vannucchi AM (2013). Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis.. HAEMATOLOGICA, vol. 98, pp. e101-e102, ISSN:0390-6078 DOI

Lombardini, L; Bosi, Alberto; Grosz, S.; Pamphilon, D.; Fehily, D.; Mareri, M.; Carella, C.; Pia Mariani, M.; Pupella, S.; Grazzini, G.; Costa, A. N. (2013). Haematopoietic stem cell transplantation: A comparison between the accreditation process performed by competent authorities and JACIE in Italy. VOX SANGUINIS, vol. 105, pp. 174-176, ISSN:0042-9007 DOI

Finke, Jürgen; Schmoor, Claudia; Bethge, Wolfgang A.; Ottinger, Hellmut D.; Stelljes, Matthias; Zander, Axel R.; Volin, Liisa; Heim, Dominik A.; Schwerdtfeger, Rainer; Kolbe, Karin; Mayer, Jiri; Maertens, Johan A.; Linkesch, Werner; Holler, Ernst; Koza, Vladimir; Bornhäuser, Martin; Einsele, Hermann; Bertz, Hartmut; Grishina, Olga; Socié, Gérard; Schneeberger, H.; Börner, G.; Gamperl, H. J.; Jauch, J.; Petan, J.; Kainz, A.; Schmoor, C.; Grishina, O.; Müller, C. h.; Scheele, J.; Schilling, B.; Kaufmann, M.; Tostmann, R.; Kollmer, A.; Nuss, S.; Wenig, C.; Bertz, H.; Egger, M.; Bethge, W. A.; Einsele, H.; Müller, R. K. F.; Ḧntschel, M.; Ottinger, H. D.; Trenschel, R.; Stelljes, M.; Zander, A. R.; Kröger, N. M.; Ayuketang, F. A.; Wolschke, C.; Schwerdtfeger, R.; Kaltenḧuser, J.; Stübig, T.; Taube, R. H.; Kolbe, K.; Thomas, S.; Ullmann, A.; Schulze Bergkamen, A.; Holler, E.; Hahn, J.; Bornḧuser, M.; Kolb, H. J.; Reibke, R.; Wandt, H.; Schaefer Eckart, K.; Socie, G.; Gluckman, E.; Esperou, H.; Robin, M.; Michallet, M.; Nicolini, F.; Null, Buzyn A.; Rubio, M. T.; Yakoub Agha, I.; Jouet, J. P.; Petillon, M. O.; Bordigoni, P.; Clement, L.; Salmon, A.; Feugier, P.; Ruutu, T.; Volin, L.; Juvonen, E.; Nihtinen, A.; Remes, K.; Putkonen, M.; Iẗl̈, M.; Kauppila, ; Mayer, J.; Krejci, M.; Brychtova, Y.; Koza, V.; Karas, M.; Voglova, J.; Lebavy, J.; Zak, P.; Heim, D.; Gratwohl, A.; Passweg, J.; Arber, C.; Tsakiris, A.; Linkesch, W.; Reitter, S.; Staber, P. B.; Lutz, D.; Krieger, O.; Maertens, J. A.; Theunissen, K.; Boogaerts, M.; Verhoef, G.; Rowe, J.; Rosenvald Zuckermann, T.; Shapira, M.; Or, R.; Resnik, I.; Nagler, A.; Shimoni, A.; Yerushalmi, R.; Sierra, J.; Valcarcel, D.; Perez Simon, J. A.; Astorga, M.; Bosi, Alberto; Guidi, S. (2012). Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 18, pp. 1716-1726, ISSN:1083-8791 DOI

Susini MC; Masala G; Antonioli E; Pieri L; Guglielmelli P; Palli D; Bosi A; Vannucchi AM (2012). Risk of second cancers in chronic myeloproliferative neoplasms. BLOOD, vol. 119, pp. 3861-3862, ISSN:0006-4971 DOI

Gian Luigi Mancardi ;Maria Pia Sormani; Massimo Di Gioia; Luisa Vuolo ;Francesca Gualandi; Maria Pia Amato; Elisabetta Capello; Daniela Currò ; Antonio Uccelli; Antonio Bertolotto; Claudio Gasperini; Alessandra Lugaresi ; Elisa Merelli; Giuseppe Meucci; Luisa Motti; Maria Rosaria Tola; Elio Scarpini; Anna Repice A;Massacesi L;Riccardo Saccardi; Alberto Bosi; The Italian BMT Study Group (2012). Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.. MULTIPLE SCLEROSIS, vol. 18, pp. 835-842, ISSN:1352-4585 DOI Accesso ONLINE all'editore

Rigacci, Luigi; Puccini, B; Dodero, A; Iacopino, P; Castagna, L; Bramanti, S; Ciceri, F; Fanin, R; Rambaldi, A; Falda, M; Milone, G; Guidi, S; Martelli, Mf; Mazza, P; Oneto, R; Bosi, Alberto; Gruppo Italiano Trapianto di Midollo Osseo, (2012). Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.. ANNALS OF HEMATOLOGY, vol. 91, pp. 931-939, ISSN:0939-5555 DOI

Sieni, Elena; Cetica, Valentina; Piccin, Andrea; Gherlinzoni, Filippo; Sasso, Ferdinando Carlo; Rabusin, Marco; Attard, Luciano; Bosi, Alberto; Pende, Daniela; Moretta, Lorenzo; Aricò, Maurizio (2012). Familial Hemophagocytic Lymphohistiocytosis May Present during Adulthood: Clinical and Genetic Features of a Small Series. PLOS ONE, vol. 7, pp. 0-0, ISSN:1932-6203 DOI Accesso ONLINE all'editore

S. Baldini; M. Fambrini; V. Carrai; L. Rigacci; R. Alterini; A. Bosi (2012). Romiplostim overcomes refractory secondary immune thrombocytopenia in a patient affected by serous ovarian carcinoma. INTERNATIONAL CANCER CONFERENCE JOURNAL, pp. 239-242, ISSN:2192-3183 DOI

Deliliers, G; Baldini, L; Onida, F; Annaloro, C; La Nasa, G; Ledda, A; Zaccaria, A; Cellini, C; De Fabritiis, P; Caravita, T; Siniscalchi, A; Cascavilla, N; Bosi, A (2012). Bortezomib-thalidomide-dexamethasone is superior to thalidomide- dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma. BLOOD, vol. 120, pp. 9-19, ISSN:0006-4971 DOI Accesso ONLINE all'editore

Baldini, S; Rigacci, L; Carrai, Valentina; Alterini, R; Fjerza, Rajmonda; Bosi, Alberto (2012). Patients with ≥ 20 × 10(9)/L Platelets at Baseline May Have a Prompt Response to Romiplostim During the Early Phase of Treatment: an Italian Single-Institution Experience.. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, vol. 4, pp. 110-119, ISSN:2035-3006 DOI

Buchi F; Spinelli E; Masala E; Gozzini A; Sanna A; Bosi A; Ferrari G; Santini V. (2012). Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine.. LEUKEMIA RESEARCH, vol. 36, pp. 607-618, ISSN:0145-2126 DOI

Susini, Mc; Masala, G; Antonioli, Elisabetta; Pieri, Lisa; Guglielmelli, P; Palli, D; Bosi, Alberto; Vannucchi, Am (2012). Risk of second cancers in chronic myeloproliferative neoplasms.. BLOOD, vol. 119, pp. 3861-3862, ISSN:0006-4971 DOI

B. Scappini; G. Gianfaldoni; F. Caracciolo; F. Mannelli; C. Biagiotti; C. Romani; EM. Pogliani; F. Simonetti; L. Borin; R. Fanci; I. Cutini; G. Longo; MC. Susini; E. Angelucci; A. Bosi (2012). Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. AMERICAN JOURNAL OF HEMATOLOGY, vol. 87, pp. 1047-1051, ISSN:1096-8652 DOI

F.DONNARUMMA; C.INDORATO; G.MASTROMEI; E.GOTI; P.NICOLETTI; P.PECILE; R.FANCI; A.BOSI; E.CASALONE (2012). Molecular analysis of population structure and antibiotic resistance of Klebsiella isolates from a three-year surveillance program in Florence hospitals, Italy. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, vol. 31, pp. 371-378, ISSN:0934-9723

L. Pieri; M.L. Iorno; E. DiFonzo; F. Almerigogna; N. Pimpinelli; C. Cardinali; E. Antonioli; P. Guglielmelli; A. Bosi; P. Fabbri; A.M. Vannucchi (2012). Mastocitosi: approccio multidisciplinare a una patologia misconoscciuta. TOSCANA MEDICA, vol. XXIX (1), pp. 47-49, ISSN:2611-9412

Antonioli, E; Guglielmelli, P; Pieri, L; Finazzi, M; Rumi, E; Martinelli, V; Vianelli, N; Randi, Ml; Bertozzi, I; De Stefano, V; Za, T; Rossi, E; Ruggeri, M; Elli, E; Cacciola, R; Cacciola, E; Pogliani, E; Rodeghiero, F; Baccarani, M; Passamonti, F; Finazzi, G; Rambaldi, A; Bosi, A; Cazzola, M; Barbui, T; Vannucchi, Am (2012). Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN. AMERICAN JOURNAL OF HEMATOLOGY, vol. 87, pp. 552-554, ISSN:0361-8609 DOI

Carrai V; Donnini I; Mazzanti B; Alterini R; Amato MP; Barilaro A;Bosi A; Massacesi L; Portaccio E; Repice AM; Rotunno G Saccardi R. (2012). Immunohistochemistry analsis of bone marrow biopies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation.. CLINICAL NEUROLOGY AND NEUROSURGERY, pp. 0-0, ISSN:0303-8467

Carrai, V; Miniati, I; Guiducci, Serena; Capaccioli, G; Alterini, R; Saccardi, Riccardo; Conforti, Ml; Rigacci, Luigi; Rotunno, G; Bosi, Alberto; Cerinic, Mm (2012). Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis.. RHEUMATOLOGY, vol. 51, pp. 1042-1048, ISSN:1462-0324 DOI

Patriarca, F; Einsele, H; Spina, F; Bruno, B; Isola, M; Nozzoli, C; Nozza, A; Sperotto, A; Morabito, F; Stuhler, G; Festuccia, M; Bosi, Alberto; Fanin, R; Corradini, P. (2012). Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availability.. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 18, pp. 617-626, ISSN:1083-8791 DOI

Raimondi R;Tosetto A;Oneto R;Cavazzina R;Rodeghiero F;Bacigalupo A;Fanin R;Rambaldi A;Bosi A (2012). Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study.. BLOOD, vol. 120, pp. 1-5, ISSN:0006-4971 DOI Accesso ONLINE all'editore

Rambaldi, A; Bacigalupo, A; Fanin, R; Ciceri, F; Bonifazi, F; Falda, M; Lambertenghi Deliliers, G; Benedetti, F; Bruno, B; Corradini, P; Alessandrino, Pe; Iacopino, P; Arcese, W; Scimè, R; Raimondi, R; Sica, S; Castagna, L; Lamparelli, T; Oneto, R; Lombardini, L; Pollichieni, S; Algarotti, A; Carobbio, A; Sacchi, N; Bosi, Alberto (2012). Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients.. LEUKEMIA, vol. 26, pp. 1-5, ISSN:0887-6924 DOI

Pierelli, L; Perseghin, P; Marchetti, M; Accorsi, P; Fanin, R; Messina, C; Olivieri, A; Risso, M; Salvaneschi, L; Bosi, Alberto; Società Italiana Di Emaferesi, ; Manipolazione, Cellulare; Gruppo Italiano Trapianto Midollo Osseo, (2012). Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process.. TRANSFUSION, vol. 52, pp. 893-905, ISSN:0041-1132 DOI

Mounier, N; Canals, C; Gisselbrecht, C; Cornelissen, J; Foa, R; Conde, E; Maertens, J; Attal, M; Rambaldi, A; Crawley, C; Luan, Jj; Brune, M; Wittnebel, S; Cook, G; van Imhoff, Gw; Castagna, L; Russell, Nh; Jouet, Jp; Cortelazzo, S; Bosi, Alberto; Irrera, G. (2012). High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, pp. 788-793, ISSN:1523-6536

Lutterotti A; Jelcić I; Schulze C; Schippling S; Breiden P; Mazzanti B; Reinhardt S; Di Gioia M; Repice A; Massacesi L; Sputtek A; Salinas-Riester G; Kroeger N; Sospedra M; Saccardi R; Zander A; Martin R.; Bosi A. (2012). No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients.. MULTIPLE SCLEROSIS, vol. 18 (8), pp. 1188-1192, ISSN:1352-4585 DOI Accesso ONLINE all'editore

Spolverini A; Pieri L; Guglielmelli P; Pancrazzi A; Fanelli T; Paoli C;Bosi A; Vannucchi AM (2012). LNK MUTATIONS IN JAK2 NEGATIVE ERYTHROCYTOSIS. In: XII Congress of the Italian Society of Experimental Hematology, Roma, Ferrata Storti Foundation, pp. 128-128.

Rigacci, L; Puccini, B; Cortelazzo, S; Gaidano, G; Piccin, A; D'Arco, A; Freilone, R; Storti, S; Orciuolo, E; Zinzani, Pl; Zaja, F; Bongarzoni, V; Balzarotti, M; Rota Scalabrini, D; Patti, C; Gobbi, M; Carpaneto, A; Liberati, Am; Bosi, Alberto; Iannitto, E. (2012). Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).. ANNALS OF HEMATOLOGY, vol. 91, pp. 1013-1022, ISSN:0939-5555 DOI

Scappini B;Gianfaldoni G;Caracciolo F;Mannelli F;Biagiotti C;Romani C;Pogliani EM;Simonetti F;Borin L;Fanci R;Cutini I;Longo G;Susini MC;Angelucci E;Bosi A (2012). Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients.. AMERICAN JOURNAL OF HEMATOLOGY, vol. 87, pp. 1047-1051, ISSN:0361-8609 DOI

Spinelli E;Caporale R;Buchi F;Masala E;Gozzini A;Sanna A;Sassolini F;Valencia A;Bosi A;Santini V (2012). Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.. CLINICAL CANCER RESEARCH, vol. 18, pp. 3079-3089, ISSN:1078-0432 DOI

Buchi, Francesca; Spinelli, E; Masala, E; Gozzini, A; Sanna, A; Bosi, Alberto; Ferrari, G; Santini, Valeria (2012). Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine.. LEUKEMIA RESEARCH, vol. 36, pp. 607-618, ISSN:0145-2126 DOI

Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V. (2012). Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.. CLINICAL CANCER RESEARCH, vol. 18, pp. 3079-3089, ISSN:1078-0432 DOI

Baldini S;Rigacci L;Carrai V;Fjerza R;Alterini R;Bosi A (2012). Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities.. PLATELETS, pp. 1-5, ISSN:0953-7104 DOI

Maria Ida Bonetti; Michela Santosuosso; Benedetta Mazzanti; Serena Urbani; Alessandra Aldinucci; Clara Ballerini; Riccardo Saccardi; Alberto Bosi; Paolo Romagnoli (2012). CD133+ cells in culture with rosiglitazone differentiate in fully differentiated Langerhans cells. EXPERIMENTAL DERMATOLOGY, vol. 21, pp. e4-e4, ISSN:0906-6705 DOI

Carrai V; Miniati I; Guiducci S; Capaccioli G; Alterini R; Saccardi R; Conforti ML; Rigacci L; Rotunno G; Bosi A; Matucci Cerinic M (2012). Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. RHEUMATOLOGY, vol. 51(6), pp. 1042-1048, ISSN:1462-0324

E. Masala; A. Valencia; F. Buchi; D. Nosi; E. Spinelli; A. Gozzini; F. Sassolini; A. Sanna; S. Zecchi; A. Bosi; V. Santini (2012). Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells.. LEUKEMIA RESEARCH, vol. 36, pp. 1290-1295, ISSN:0145-2126 DOI

Mannelli F;Bencini S;Peruzzi B;Cutini I;Sanna A;Benelli M;Magi A;Gianfaldoni G;Rotunno G;Carrai V;Gelli AM;Valle V;Santini V;Notaro R;Luzzatto L;Bosi A (2012). A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.. CYTOMETRY. PART B, CLINICAL CYTOMETRY, pp. 1-2, ISSN:1552-4949 DOI

Mannelli F;Gianfaldoni G;Intermesoli T;Cattaneo C;Borlenghi E;Cortelazzo S;Cavattoni I;Pogliani EM;Fumagalli M;Angelucci E;Romani C;Ciceri F;Corti C;Scattolin AM;Cortelezzi A;Mattei D;Audisio E;Spinelli O;Oldani E;Bosi A;Rambaldi A;Bassan R (2011). CD20 expression has no prognostic role in Philadelphia-negativeB-precursor acute lymphoblastic leukemia: new insights from the molecularstudy of minimal residual disease.. HAEMATOLOGICA, vol. 97, pp. 568-571, ISSN:0390-6078 DOI

Buchi F; Pastorelli R; Ferrari G; Spinelli E; Gozzini A; Sassolini F; Bosi A; Tombaccini D; Santini V (2011). Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.. LEUKEMIA RESEARCH, vol. 35, pp. 921-931, ISSN:0145-2126 DOI

R. Fanci; S. Fallani; S. Bencini; A. Novelli; A. Bosi (2011). Therapeutic drug monitoring (TDM) of posaconazole in acute leukemia patients: preliminary results of a monocentric experience. HAEMATOLOGICA, vol. 96 (s3), pp. 107-108, ISSN:1592-8721

Napoli C; Nobili S; Landini I; Perrone G; Valenti A; Brugia M; Puccini B; Antognoli G; Doria M; Martelli M; Finolezzi E; Rigacci L; Di Lollo S; Bosi A; Mini E (2011). Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma. BLOOD, vol. 118, pp. 2478-2478, ISSN:0006-4971

A.M. Vannucchi; E. Antonioli; P. Guglielmelli; L. Pieri; A. Pancrazzi; A. Bosi (2011). Percorsi diagnostici-terapeutici per le neoplasie mieloproliferative nella AOU Careggi. TOSCANA MEDICA, vol. xxix(4), pp. 46-48, ISSN:2611-9412

M.I. Bonetti; L. Pieri; L. Domenici; S. Urbani; G. Romano; A. Aldinucci; C. Ballerini; M. Monici; R. Saccardi; V. Basile; A. Bosi; P. Romagnoli (2011). Dendritic cells with lymphocyte stimulating activity differentiate from human CD133 positive precursors.. BLOOD, vol. 117, pp. 3983-3995, ISSN:0006-4971 DOI Accesso ONLINE all'editore

Marty FM, Ljungman P, Papanicolaou GA, Winston DJ, Chemaly RF, Strasfeld L, Young JA, Rodriguez T, Maertens J, Schmitt M, Einsele H, Ferrant A, Lipton JH, Villano SA, Chen H, Boeckh M; Bosi A (2011). Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. THE LANCET INFECTIOUS DISEASES, vol. 11, pp. 284-292, ISSN:1473-3099

Baldomero, H; Gratwohl, M; Gratwohl, A; Tichelli, A; Niederwieser, D; Madrigal, A; Frauendorfer, K; Bosi, Alberto (2011). European Group for Blood and Marrow Transplantation EBMT. The EBMT activity survey 2009: trends over the past 5 years.. BONE MARROW TRANSPLANTATION, vol. 46, pp. 485-501, ISSN:0268-3369

L. Pieri; A. Spolverini;B. Scappini;U. Occhini;S. Birtolo;A. Bosi;F. Albano;C. Fava;A.M. Vannucchi (2011). Concomitant occurrence of BCR-ABL and JAK2V617F mutation.. BLOOD, vol. 118(12), pp. 3445-3446, ISSN:0006-4971

Donnini I; Scappini B; Guidi S; Longo G; Bosi A (2011). Acquired severe aplastic anemia after H1N1 influenza virus vaccination successfully treated with allogeneic bone marrow transplantation. ANNALS OF HEMATOLOGY, vol. ..., pp. 30-33, ISSN:0939-5555

Alessandrino EP; Angelucci E; Cazzola M; Porta MG; Di Bartolomeo P; Gozzini A; Malcovati L; Pioltelli P; Sica S; Bosi A (2011). Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo. AMERICAN JOURNAL OF HEMATOLOGY, vol. .., pp. 17-34, ISSN:0361-8609

Barosi G; Bosi A; Abbracchio MP; Danesi R; Genazzani A; Corradini P; Pane F; Tura S. (2011). Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation.. HAEMATOLOGICA, vol. 96, pp. 937-942, ISSN:0390-6078

Patriarca F; Einsele H; Spina F; Bruno B; Isola M; Nozzoli C; Nozza A; Sperotto A; Morabito F; Stuhler G; Festuccia M; Bosi A; Fanin R; Corradini P (2011). Allogeneic Stem Cell Transplantation In Multiple Myeloma Relapsed After Autograft: A Multicenter Retrospective Study Based on Donor Availability.. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. ...., pp. 34-44, ISSN:1083-8791

Messori A; Maratea D; Nozzoli C; Bosi A (2011). The role of bortezomib, thalidomide and lenalidomide in the management of multiple myeloma: an overview of clinical and economic information.. PHARMACOECONOMICS, vol. 29, pp. 269-285, ISSN:1170-7690

Pierelli L; Perseghin P; Marchetti M; Accorsi P; Fanin R; Messina C; Olivieri A; Risso M; Salvaneschi L; Bosi A (2011). Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process.. TRANSFUSION, vol. ...., pp. 20-30, ISSN:1537-2995

Rigacci L; Landi C; Caruso JP; Puccini B; Alterini R; Carrai V; Perrone T; Bosi A. (2011). Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients.. LEUKEMIA, vol. ...., pp. 54-59, ISSN:0887-6924

Björkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Gahrton G (2011). Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.. JOURNAL OF CLINICAL ONCOLOGY, vol. 29, pp. 3016-3022, ISSN:0732-183X

Olivieri A; Marchetti M; Lemoli R; Tarella C; Iacone A; Lanza F; Rambaldi A; Bosi A. (2011). Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo italianoTrapianto di Midollo Osseo. BONE MARROW TRANSPLANTATION, vol. ...., pp. 25-30, ISSN:0268-3369

Massi D; Fondi C; Nozzoli C; Benemei S; Lapi F; Albarello L; Avellini C; Bonoldi E; Casini M; Cesinaro AM; Ciceri F; Colombetti V; Comin CE; Donelli A; Fortunato M; Fratoni S; Guidi S; Messerini L; Milone G; Rapezzi D; Negri G; Patriarca F; Peccatori FA; Ponzoni M; Rafaniello P; Raimondi R; Salomone E; Tendas A; Villari L; Santucci M; Bosi A. (2011). The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo. HUMAN PATHOLOGY, pp. 254-268, ISSN:0046-8177 DOI

Biamonte F;Guglielmelli P;Fanelli T;Pancrazzi A;Villani L;Bosi A;Barosi G;Vannucchi AM (2011). ANALYSIS OF ASXL1 MUTATIONS IN 215 PATIENTS WITH MYELOFIBROSIS : IMPACT ON DISEASE PHENOTYPE AND PROGNOSIS. In: 43° Congress of the Italian Society of Hematology, Ferrata Storti Foundation, pp. 31-31.

Guglielmelli P; Biamonte F; Score J; Hidalgo-Curtis C; Cervantes F; Maffioli M; Fanelli T; Ernst T; Winkelman N; Jones AV; Zoi K; Reiter A; Duncombe A; Villani L; Bosi A; Barosi G; Cross NC; Vannucchi AM (2011). EZH2 mutational status predicts poor survival in myelofibrosis.. BLOOD, vol. 2011 Nov 10;118(19):5227-34., pp. 5227-5234, ISSN:0006-4971 DOI Accesso ONLINE all'editore

Rigacci L; Puccini B; Iovino L; Martelli M; Finolezzi E; DI Lollo S; Doria M; Bosi A. (2011). Impact of dose-dense immunochemotherapy on prognosis of germinal center and non germinal center origin of diffuse large B cell lymphoma.. JOURNAL OF CHEMOTHERAPY, vol. 23, pp. 227-231, ISSN:1973-9478

Santini V; Girelli D; Sanna A; Martinelli N; Duca L; Campostrini N; Cortelezzi A; Corbella M; Bosi A; Reda G; Olivieri O; Cappellini MD (2011). Hepcidin levels and their determinants in different types of myelodysplastic syndromes. PLOS ONE, vol. 6, pp. 0-0, ISSN:1932-6203 DOI

Pieri L; Urbani S; Mazzanti B; Pozzo SD; Santosuosso M; Saccardi R; Bosi A; Faussone-Pellegrini MS; Vannucchi MG ; (2011). Human mesenchymal stromal cells preserve their stem features better when cultured in the Dulbecco's modified Eagle medium.. CYTOTHERAPY, vol. 13, pp. 539-548, ISSN:1465-3249

R.Fanci; P. Pecile; E. Casalone; S. Bencini; R. Fjerza; G. Mastromei; A. Bosi (2011). Nosocomial infections in hematologic patients : 4-year epidemiologic survey. HAEMATOLOGICA, vol. 96 ( s3), pp. 23-23, ISSN:0390-6078

Buchi, F; Pastorelli, R; Ferrari, G; Spinelli, E; Gozzini, A; Sassolini, F; Bosi, Alberto; Tombaccini, D; Santini, Valeria (2011). Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.. LEUKEMIA RESEARCH, vol. 35, pp. 921-931, ISSN:0145-2126 DOI

Pasi A; Crocchiolo R; Bontempelli M; Carcassi C; Carella G; Crespiatico L; Garbarino L; Mascaretti L; Mazzi B; Mazzola G; Miotti V; Porfirio B; Tagliaferri C; Valentini T; Vecchiato C; Fleischhauer K; Sacchi N; Bosi A; Martinetti M (2011). The conundrum of HLA-DRB1*14:01/*14:54 and HLA-DRB3*02:01/*02:02 mismatches in unrelated hematopoietic SCT.. BONE MARROW TRANSPLANTATION, vol. 46, pp. 916-922, ISSN:0268-3369

Guglielmelli, P.; Tozzi, L.; Bogani, C.; Iacobucci, I.; Ponziani, V.; Martinelli, G.; Bosi, A.; Vannucchi, A.M. . (2011). Overexpression of microRNA-16-2 contributes to the abnormalerythropoiesis in polycythemia vera.. BLOOD, vol. 117(25), pp. 6923-6927, ISSN:0006-4971 DOI Accesso ONLINE all'editore

Guglielmelli, Paola; Barosi, Giovanni; Rambaldi, Alessandro; Marchioli, Roberto; Masciulli, Arianna; Tozzi, Lorenzo; Biamonte, Flavia; Bartalucci, Niccolò; Gattoni, Elisabetta; Lupo, Maria Letizia; Finazzi, Guido; Pancrazzi, Alessandro; Antonioli, Elisabetta; Susini, Maria Chiara; Pieri, Lisa; Malevolti, Elisa; Usala, Emilio; Occhini, Ubaldo; Grossi, Alberto; Caglio, Silvia; Paratore, Simona; Bosi, Alberto; Barbui, Tiziano; Vannucchi, Alessandro M (2011). Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis. BLOOD, vol. 118, pp. 2069-2076, ISSN:0006-4971 DOI Accesso ONLINE all'editore

Pieri L; Bosi A; Vannucchi AM. (2010). Imatinib and cardiac failure in idiopathic hypereosinophilic syndrome.. ANNALS OF HEMATOLOGY, vol. 89(7), pp. 745-746, ISSN:0939-5555

Antonioli E; Carobbio A; Pieri L; Pancrazzi A; Guglielmelli P; Delaini F; Ponziani V; Bartalucci N; Tozzi L; Bosi A; Rambaldi A; Barbui T; Vannucchi A (2010). Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia.. HAEMATOLOGICA, vol. 95, pp. 1435-1438, ISSN:0390-6078 DOI

Gianfaldoni G;Mannelli F;Ponziani V;Longo G;Bencini S;Bosi A;Vannucchi AM (2010). Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia.. HAEMATOLOGICA, vol. 95, pp. 833-836, ISSN:0390-6078 DOI

Rigacci, L; Fabbri, A; Puccini, B; Chitarrelli, I; Chiappella, A; Vitolo, U; Levis, A; Lauria, F; Bosi, Alberto (2010). Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin) +/- rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma.. CANCER, vol. JUN, pp. 0-0, ISSN:1045-7410

Lo-Coco F; Avvisati G; Vignetti M; Breccia M; Gallo E; Rambaldi A; Paoloni F; Fioritoni G; Ferrara F; Specchia G; Cimino G; Diverio D; Borlenghi E; Martinelli G; Di Raimondo F; Di Bona E; Fazi P; Peta A; Bosi A; Carella AM; Fabbiano F; Pogliani EM; Petti MC; Amadori S; Mandelli F (2010). Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults patients younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.. BLOOD, vol. JUL, pp. 0-0, ISSN:0006-4971

Cavo M, Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, Di Raimondo F, Crippa C, Zamagni E, Palumbo A, Offidani M, Corradini P, Narni F, Spadano A, Pescosta N, Deliliers GL, Ledda A, Cellini C, Caravita T, Tosi P, Baccarani M; GIMEMA Italian Myeloma Network; Bosi A (2010). Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.. THE LANCET, vol. 376, pp. 2075-2085, ISSN:0140-6736

Guiducci S; Porta F; Saccardi R; Guidi S; Ibba-Manneschi L; Manetti M; Mazzanti B; Dal Pozzo S; Milia AF; Bellando-Randone S; Miniati I; Fiori G; Fontana R; Amanzi L; Braschi F; Bosi A; Matucci-Cerinic M (2010). Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report. ANNALS OF INTERNAL MEDICINE, vol. 153, pp. 650-654, ISSN:0003-4819 DOI

Lemoli, Rm; D'Addio, A; Marotta, G; Pezzullo, L; Zuffa, E; Montanari, M; De Vivo, A; Bonini, A; Galieni, P; Carella, Am; Guidi, S; Michieli, M; Olivieri, A; Bosi, Alberto (2010). BU/melphalan and auto-SCT in AML patients in first CR: a 'Gruppo Italiano Trapianto di Midollo Osseo (GITMO)' retrospective study.. BONE MARROW TRANSPLANTATION, vol. 45, pp. 640-646, ISSN:0268-3369

Alessandrino, Ep; Della Porta MG, ; Bacigalupo, A; Malcovati, L; Angelucci, E; Van Lint MT, ; Falda, M; Onida, F; Bernardi, M; Guidi, S; Lucarelli, B; Rambaldi, A; Cerretti, R; Marenco, P; Pioltelli, P; Pascutto, C; Oneto, R; Pirolini, L; Fanin, R; Bosi, Alberto (2010). Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).. HAEMATOLOGICA, vol. 95, pp. 476-484, ISSN:0390-6078 Accesso ONLINE all'editore

S. D. Pozzo;S. Urbani;B. Mazzanti;P. Luciani;C. Deledda;L. Lombardini;S. Benvenuti;A. Peri;A. Bosi;R. Saccardi (2010). High recovery of mesenchymal progenitor cells with non-density gradient separation of human bone marrow.. CYTOTHERAPY, vol. 12, pp. 579-586, ISSN:1465-3249 DOI Accesso ONLINE all'editore

P. Guglielmelli;F. Biamonte;A. Spolverini;L. Pieri;A. Isgrò;E. Antonioli;A. Pancrazzi;A. Bosi;G. Barosi;A.M. Vannucchi (2010). Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis.. LEUKEMIA, vol. 24(8), pp. 1533-1537, ISSN:0887-6924

Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM; A. Bosi (2010). Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.. THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 362, pp. 2251-2259, ISSN:0028-4793

Patriarca, F; Bacigalupo, A; Sperotto, A; Isola, M; Bruno, B; van Lint, Mt; Iori, Ap; Di Bartolomeo, P; Musso, M; Pioltelli, P; Visani, G; Iacopino, P; Fanin, R; Bosi, Alberto (2010). Outcome of allogeneic stem cell transplantation following reduced-intensity conditioninig regimen in patients with idiopathic myelofibrosis: the g.I.T.m.o. Experience.. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, pp. 010-012, ISSN:2035-3006

S. Guiducci; F. Porta; R. Saccardi; S. Guidi; L. Ibba-Manneschi; M. Manetti; B. Mazzanti; S. Dal Pozzo; A.F. Milia; S. Bellando-Randone; I. Miniati; G. Fiori; R. Fontana; L. Amanzi; F. Braschi; A. Bosi; M. Matucci-Cerinic (2010). Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report. ANNALS OF INTERNAL MEDICINE, vol. 153, pp. 650-654, ISSN:0003-4819

Bosi A; Bartolozzi B. (2010). Safety of Bone Marrow Stem Cell Donation: A Review.. TRANSPLANTATION PROCEEDINGS, vol. 42, pp. 2192-2194, ISSN:0041-1345

Napoli C; Nobili S; Landini I; Perrone G; Puccini B; Antognoli G; Doria M; Martelli M; Finolezzi E; Rigacci L; Di Lollo S; Bosi A; Mini E (2010). Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results. HAEMATOLOGICA, vol. 95 (Suppl 3), pp. S95-S95, ISSN:0390-6078

A. Petrarca; L. Rigacci; P. Caini; S. Colagrande; P. Romagnoli; F. Vizzutti; U. Arena; C.Giannini; M. Monti; P. Montalto; M. Matucci-Cerinic; A. Bosi; G. Laffi; A.L. Zignego. (2010). Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease. BLOOD, vol. 116, pp. 335-342, ISSN:0006-4971 DOI Accesso ONLINE all'editore

F.DONNARUMMA; S.SERGI; C.INDORATO; G.MASTROMEI; R.MONNANNI; P.NICOLETTI; P.PECILE; D.CECCONI; R.MANNINO; S.BENCINI; R.FANCI; A.BOSI; E.CASALONE (2010). Molecular characterization of Acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysis. JOURNAL OF CLINICAL MICROBIOLOGY, vol. 48, pp. 1297-1304, ISSN:0095-1137

Gorin, Nc; Labopin, M; Reiffers, J; Milpied, N; Blaise, D; Witz, F; de Witte, T; Meloni, G; Attal, M; Bernal, T; Rocha, V; Guyotat, D; Bosi, Alberto; Feremans, W. (2010). Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.. BLOOD, pp. 3157-3162, ISSN:0006-4971

Pagano, L; Caira, M; Nosari, A; Rossi, G; Locatelli, F; Viale, P; Aversa, F; La Nasa, G; Storti, S; Giustolisi, R; Morabito, F; Cuneo, A; Bosi, Alberto (2010). Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies.. JOURNAL OF CHEMOTHERAPY, pp. 20-24, ISSN:1973-9478

Gianfaldoni G; Mannelli F; Ponziani V; Longo G; Bencini S; Bosi A; Vannucchi AM. (2010). Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia.. HAEMATOLOGICA, vol. 95(8), pp. 1435-1438, ISSN:0390-6078

Mannelli, F; De Simone, P; Gianfaldoni, G; Nozzoli, C; Filipponi, F; Bosi, Alberto (2009). Atypical acute leukemia early after liver transplantation.. TRANSPLANTATION PROCEEDINGS, vol. 41, pp. 3945-3946, ISSN:0041-1345

Fondi, C; Nozzoli, C; Benemei, Silvia; Baroni, G; Saccardi, R; Guidi, S; Nicoletti, P; Bartolozzi, B; Pimpinelli, Nicola; Santucci, Marco; Bosi, Alberto; Massi, Daniela (2009). Increase in FOXP3(+) Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 15, pp. 938-947, ISSN:1083-8791 DOI Accesso ONLINE all'editore

Girmenia, C; Barosi, G; Aversa, F; Bacigalupo, A; Barbui, T; Baronciani, D; Bosi, Alberto; Candoni, A; Locasciulli, A; Locatelli, F; Menichetti, F; Musso, M; Viscoli, C; Rambaldi, A. (2009). Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO).. CLINICAL INFECTIOUS DISEASES, vol. 49, pp. 1226-1236, ISSN:1058-4838

Miniati I.; Guiducci S.; Conforti M.L.; Rogai V.; Fiori G.; Cinelli M.; Saccardi R.; Guidi S.; Bosi A.; Tyndall A.; Matucci-Cerinic M. (2009). Autologous stem cell transplantation improves microcirculation in systemic sclerosis. ANNALS OF THE RHEUMATIC DISEASES, vol. 68, pp. 94-98, ISSN:0003-4967

Gratwohl A; Stern M; Brand R; Apperley J; Baldomero H; de Witte T; Dini G; Rocha V; Passweg J; Sureda A; Tichelli A; Niederwieser D; Bosi A (2009). European Group for Blood and Marrow Transplantation and the European Leukemia Net. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.. CANCER, vol. 115, pp. 4715-4726, ISSN:1045-7410

De Stefano, V; Za, T; Rossi, E; Vannucchi, Am; Ruggeri, M; Elli, E; Micò, C; Tieghi, A; Cacciola, Rr; Santoro, C; Vianelli, N; Guglielmelli, P; Pieri, L; Scognamiglio, F; Cacciola, E; Rodeghiero, F; Pogliani, Em; Finazzi, G; Gugliotta, L; Leone, G; Barbui, T; Bosi, A; Ruggeri, M; Scognamiglio, F (2009). Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.. ANNALS OF HEMATOLOGY, pp. 141-146, ISSN:0939-5555

P. Guglielmelli; G. Barosi; L. Pieri; E. Antonioli; A. Bosi; A.M. Vannucchi (2009). JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis. HAEMATOLOGICA, vol. 94, pp. 144-146, ISSN:0390-6078 DOI

Vannucchi AM; Masala G; Antonioli E; Chiara Susini M; Guglielmelli P; Pieri L; Maggi L; Caini S; Palli D; Bogani C; Ponziani V; Pancrazzi A; Annunziato F; Bosi A. (2009). Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, vol. 18(7), pp. 2068-2073, ISSN:1055-9965

R Fanci ; B Bartolozzi ; S Sergi ; E Casalone ; P Pecile ; D Cecconi ; R Mannino ; F Donnarumma ; AG Leon ; S Guidi ; P Nicoletti ; G Mastromei ; A Bosi (2009). Molecular epidemiological investigation of an outbreak of Pseudomonas aeruginosa infection in an SCT unit.. BONE MARROW TRANSPLANTATION, vol. 43, pp. 335-338, ISSN:0268-3369 DOI Accesso ONLINE all'editore

Robinson, Sp; Sureda, A; Canals, C; Russell, N; Caballero, D; Bacigalupo, A; Iriondo, A; Cook, G; Pettitt, A; Socie, G; Bonifazi, F; Bosi, Alberto; Michallet, M; Liakopoulou, E; Maertens, J; Passweg, J; Clarke, F; Martino, R; Schmitz, N. (2009). Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome. HAEMATOLOGICA, vol. 94, pp. 230-238, ISSN:0390-6078

Finke J; Bethge WA; Schmoor C; Ottinger HD; Stelljes M; Zander AR; Volin L; Ruutu T; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Kolb HJ; Bertz H; Egger M; Grishina O; Socié G; A Bosi (2009). Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.. THE LANCET ONCOLOGY, vol. 10, pp. 855-864, ISSN:1470-2045

Miniati I;Guiducci S;Conforti ML;Rogai V;Fiori G;Cinelli M;Saccardi R;Guidi S;Bosi A;Tyndall A;Matucci-Cerinic M (2009). Autologous stem cell transplantation improves microcirculation in systemic sclerosis.. ANNALS OF THE RHEUMATIC DISEASES, vol. 68(1), pp. 94-98, ISSN:0003-4967 DOI

Claviez, A; Canals, C; Dierickx, D; Stein, J; Badell, I; Pession, A; Mackinnon, S; Slavin, S; Dalle, Jh; Chacón, Mj; Sarhan, M; Wynn, Rf; Suttorp, M; Dini, G; Sureda, A; Schmitz, N; Bosi, Alberto (2009). Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation.. BLOOD, vol. 115, pp. 2060-2067, ISSN:0006-4971

Morra E; Barosi G; Bosi A; Ferrara F; Locatelli F; Marchetti M; Martinelli G; Mecucci C;Vignetti M; Tura S (2009). Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.. HAEMATOLOGICA, vol. 94, pp. 150-160, ISSN:0390-6078

Crocchiolo R; Zino E; Vago L; Oneto R; Bruno B; Pollichieni S; Sacchi N; Sormani MP; Marcon J; Lamparelli T; Fanin R; Garbarino L; Miotti V; Bandini G; Bosi A; Ciceri F; Bacigalupo A; Fleischhauer K (2009). Non-permissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.. BLOOD, vol. 114, pp. 1437-1444, ISSN:0006-4971

18. Bassan R; Spinelli O; Oldani E; Intermesoli T; Tosi M; Peruta B; Rossi G; Borlenghi E; Pogliani EM; Terruzzi E; Fabris P; Cassibba V; Lambertenghi-Deliliers G; Cortelezzi A; Bosi A; Gianfaldoni G; Ciceri F; Bernardi M; Gallamini A; Mattei D; Di Bona E; Romani C; Scattolin AM; Barbui T; Rambaldi A. (2009). Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).. BLOOD, vol. 113, pp. 4153-4162, ISSN:0006-4971

Crocchiolo, R; Ciceri, F; Fleischhauer, K; Oneto, R; Bruno, B; Pollichieni, S; Sacchi, N; Sormani, Mp; Fanin, R; Bandini, G; Bonifazi, F; Bosi, Alberto; Rambaldi, A; Alessandrino, Pe; Falda, M; Bacigalupo, A. (2009). HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. BONE MARROW TRANSPLANTATION, vol. 44, pp. 571-577, ISSN:0268-3369

Guglielmelli P; Barosi G; Specchia G; Rambaldi A; Lo Coco F; Antonioli E; Pieri L; Pancrazzi A; Ponziani V; Delaini F; Longo G; Ammatuna E; Liso V; Bosi A; Barbui T; Vannucchi AM. (2009). Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele.. BLOOD, vol. 114, pp. 1477-1483, ISSN:0006-4971

P. Guglielmelli; C. Fatini; M. Lenti; A. Bosi; A.M. Vannucchi (2009). JAK2V617F mutational screening in patients with retinal vein thrombosis or recurrent fetal loss.. THROMBOSIS RESEARCH, vol. 124, pp. 377-378, ISSN:0049-3848 DOI

L. Pieri ; C. Bogani ; P. Guglielmelli ; M. Zingariello ; RA. Rana ; N. Bartalucci ;A Bosi ; AM. Vannucchi (2009). The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils of polycythemia vera.. HAEMATOLOGICA, vol. 94, pp. 1537-1545, ISSN:0390-6078 DOI

A.M. Vannucchi; P. Guglielmelli; L. Pieri; E. Antonioli; A. Bosi (2009). Treatment options for essential thrombocythemia and polycythemia vera. EXPERT REVIEW OF HEMATOLOGY, vol. 2, pp. 41-55, ISSN:1747-4086 DOI

Fenaux, P; Mufti, Gj; Hellstrom Lindberg, E; Santini, Valeria; Finelli, C; Giagounidis, A; Schoch, R; Gattermann, N; Sanz, G; List, A; Gore, Sd; Seymour, Jf; Bennett, Jm; Byrd, J; Backstrom, J; Zimmerman, L; Mckenzie, D; Beach, C; Silverman, Lr; Sacchi, S; Bosi, Alberto; Musto, P; Muus, P. (2009). Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.. THE LANCET ONCOLOGY, vol. 10, pp. 223-232, ISSN:1470-2045

S Sergi ; F Donnarumma ; G Mastromei ; E Goti ; P Nicoletti ; P Pecile ; D Cecconi ; R Mannino ; R Fanci ; A Bosi ; B Bartolozzi ; E Casalone (2009). Molecular surveillance and population structure analysis of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in high-risk wards.. JOURNAL OF CLINICAL MICROBIOLOGY, vol. 47, pp. 2346-2354, ISSN:0095-1137 DOI Accesso ONLINE all'editore

B. Scappini; G. Gianfaldoni; MC. Susini; R. Fanci; S. Baldini; R. Fjerza; F. Mannelli; G. Longo; A. Bosi (2009). High dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-Myl) in relapsed or refractory AML patients. HAEMATOLOGICA, vol. 94, pp. 549-549, ISSN:1592-8721

B.Scappini; G. Gianfaldoni; P. Salvatore; MC. Susini; T. Izzo; F. Mannelli; G. Longo; R. Fanci; F. Ferrara; A. Bosi (2009). High Dose Cytarabine, Clofarabine and Gemtuzumab Ozogamicin (CLAC-MYL) in Relapsed or Refractory AML Patients.. BLOOD, vol. 114, pp. 438-438, ISSN:0006-4971

C. Cellai; A. Laurenzana; E. Bianchi; S. Sdelci; R. Manfredini; A.M. Vannucchi; R. Caporale; M. Balliu; F. Mannelli; S. Ferrari; A. Bosi; D. Miniat; P.L. Cocco; S. Veronneau; J. Stankova; F. Paoletti (2009). Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN. EXPERIMENTAL HEMATOLOGY, vol. 37, pp. 1176-1185, ISSN:0301-472X DOI Accesso ONLINE all'editore

Avivi I, Montoto S, Canals C, Maertens J, Al-Ali H, Mufti GJ, Finke J, Schattenberg A, Fanin R, Cornelissen JJ, Vernant JP, Russell N, Beguin Y, Thomson K, Verdonck LF, Kobbe G, Tilly H, Socié G, Sureda A; Bosi A (2009). Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.. BRITISH JOURNAL OF HAEMATOLOGY, vol. 147, pp. 719-728, ISSN:0007-1048

B. Bartolozzi ; R. Fanci ; S. Sergi ; P. Pecile ; D. Cecconi; R.Mannino ; E. Casalone; F. Donnarumma ; AG Leon ; C. Nozzoli ;S. Guidi ; P. Nicoletti ; G. Mastromei ; A. Bosi (2008). One-year microbiological survey with molecular typing method of Pseudomonas aeruginosa in a BMT Unit. BONE MARROW TRANSPLANTATION, vol. 41, pp. 61-61, ISSN:0268-3369

P.Sbano; A.Cuccia; B.Mazzanti; S.Urbani; B.Giusti; I.Lapini; L.Rossi; R.Abbate; G.Marseglia; G.Nannetti; F.Torricelli; C.Miracco; A.Bosi; M.Fimiani; R.Saccardi (2008). Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. ARCHIVES OF DERMATOLOGICAL RESEARCH, vol. 300, pp. 115-124, ISSN:0340-3696 DOI

Saccardi, R; Di Gioia, M; Bosi, Alberto (2008). Haematopoietic stem cell transplantation for autoimmune disorders.. CURRENT OPINION IN HEMATOLOGY, vol. 15, pp. 594-600, ISSN:1065-6251

Gianfaldoni G;Mannelli F;Bencini S;Leoni F;Baldini S;Bosi A (2008). Peripheral blood blast clearance during induction therapy in acute myeloid leukemia.. BLOOD, vol. 111, pp. 1746-1747, ISSN:0006-4971 DOI

P. Gallina; M. Paganini; R. Saccardi; B. Bartolozzi; B. Mazzanti; S. Dal Pozzo; A.M. Romoli; M. Marini; E. Sarchielli; A. Di Rita; S. Piacentini; L. Lombardini; S. Urbani; A. Bosi; G. Vannelli; N. Di Lorenzo (2008). Trapianto di tessuto striatale fetale umano nella malattia di Huntington. Primi risultati del trial clinico italiano. TRAPIANTI, vol. 12 n.3, pp. 105-114, ISSN:1590-072X

Schubert, J; Hillmen, P; Röth, A; Young, Ns; Elebute, Mo; Szer, J; Gianfaldoni, G; Socié, G; Browne, P; Geller, R; Rother, Rp; Muus, P; Antonioli, E; Mannelli, F; Bosi, A; Rodeghiero, F (2008). Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria.. BRITISH JOURNAL OF HAEMATOLOGY, pp. 263-272, ISSN:1365-2141

Baldini, S; Pupi, Alberto; DI LOLLO, Simonetta; Marchionni, Niccolo'; Shraim, R; Bosi, Alberto (2008). PET positivity with bone marrow biopsy revealing sarcoidosis in a patient in whom bone marrow metastases had been suspected. BRITISH JOURNAL OF HAEMATOLOGY, vol. 143, pp. 306-306, ISSN:0007-1048

Landini I; Napoli C; Nobili S; Morganti M; Rigacci L; Bosi A; Mini E (2008). In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles. HAEMATOLOGICA, vol. 93 (Suppl 2), pp. S49-S50, ISSN:0390-6078

Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E (2008). In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles. In: International Symposium on Cancer genotypes and Cancer phenotypes, Florence, Italy, Luglio 4-5, 2008, -, pp. 61-61.

Brand, A; Rebulla, P; Engelfriet, Cp; Reesink, Hw; Beguin, Y; Baudoux, E; Kögler, G; Ebrahimi, M; Grazzini, G; Costa, An; Bosi, A; Sacchi, N; Lombardini, L; Pupella, S; Lecchi, L; Garcidueñas, Ed; van Beckhoven, Jm; de Wit, Hj; Fibbe, We; Zhiburt, Eb; Bart, T; Beksaç, M; Navarrete, C; Regan, F. (2008). Cord blood banking.. VOX SANGUINIS, pp. 335-348, ISSN:0042-9007

R. Fanci; B. Bartolozzi; G.Longo; A.Bosi (2008). A prospective, open-label noncomparative study with piperacillin-tazobactam monotherapy as management of Fever in patients with acute leukemia.. JOURNAL OF CHEMOTHERAPY, vol. 20 (4), pp. 492-496, ISSN:1973-9478

Lorenzi B; Pessina F; Lorenzoni P; Urbani S; Vernillo R; Sgaragli G; Gerli R; Mazzanti B; Bosi A; Saccardi R; Lorenzi M (2008). Treatment of Experimental Injury of Anal Sphincters with Primary Surgical Repair and Injection of Bone Marrow-Derived Mesenchymal Stem Cells.. DISEASES OF THE COLON & RECTUM, vol. 51, pp. 411-420, ISSN:0012-3706

Alessandro M Vannucchi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro Pancrazzi; Vittoria Guerini; Giovanni Barosi; Marco Ruggeri; Giorgina Specchia; Francesco Lo-Coco; Federica Delaini; Laura Villani; Silvia Finotto; Emanuele Ammatuna; Renato Alterini; Valentina Carrai; Gloria Capaccioli; Simonetta Di Lollo; Vincenzo Liso; Alessandro Rambaldi; Alberto Bosi; Tiziano Barbui (2008). Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia.. BLOOD, vol. 112, pp. 844-847, ISSN:0006-4971

Patriarca, F; Bacigalupo, A; Sperotto, A; Isola, M; Soldano, F; Bruno, B; van Lint MT, ; Iori, Ap; Santarone, S; Porretto, F; Pioltelli, P; Visani, G; Iacopino, P; Fanin, R; Bosi, Alberto (2008). Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).. HAEMATOLOGICA, vol. 93, pp. 1514-1522, ISSN:0390-6078

Alessandrino EP; Della Porta MG; Bacigalupo A; Van Lint MT; Falda M; Onida F; Bernardi M; Lori AP; Rambaldi A; Cerretti R; Marenco P; Pioltelli P; Malcovati L; Pascutto C; Oneto R; Fanin R; Bosi A (2008). WHO classification and WPSS predict post-transplant outcome in patients with myelodysplastic syndrome: a study from the GITMO (gruppo italiano trapianto di midollo osseo).. BLOOD, vol. 93, pp. 1514-1522, ISSN:0006-4971

Sierra, J; Szer, J; Kassis, J; Herrmann, R; Lazzarino, M; Thomas, X; Noga, Sj; Baker, N; Dansey, R; Bosi, Alberto (2008). A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.. BMC CANCER, vol. 8, pp. 195-199, ISSN:1471-2407

Alessandro Pancrazzi; Paola Guglielmelli; Vanessa Ponziani; Gaetano Bergamaschi; Alberto Bosi; Giovanni Barosi; Alessandro M Vannucchi (2008). A sensitive detection method for MPLW515L or MPLW515K mutation in chronic myeloproliferative disorders with locked nucleic acid-modified probes and real-time polymerase chain reaction.. THE JOURNAL OF MOLECULAR DIAGNOSTICS, vol. 10, pp. 435-441, ISSN:1525-1578

S. Matà; S. Guidi; C. Nozzoli; A. Orsi; A. Pratesi; M. Mascalchi; M. Moretti; L. Letizia; G. Rombolà; S. Sorbi; A. Bosi (2008). Human herpesvirus 6-associated limbic encephalitis in adult recipients of unrelated umbilical cord blood transplantation.. BONE MARROW TRANSPLANTATION, vol. ..., pp. 0-0, ISSN:0268-3369

P. Gallina; M. Paganini; L. Lombardini; R. Saccardi; M. Marini; M.T. De Cristofaro; P. Pinzani; F. Salvianti; C. Crescioli; A. Di Rita; S. Bucciantini; C. Mechi; E. Sarchielli; M. Moretti; S. Piacentini; G. Gritti; A. Bosi; S. Sorbi; G. Orlandini; G.B. Vannelli; N. Di Lorenzo (2008). Development of human striatal anlagen after transplantation in a patient with Huntington's disease.. EXPERIMENTAL NEUROLOGY, vol. 213, pp. 241-244, ISSN:0014-4886

Costanza Bogani; Vanessa Ponziani; Paola Guglielmelli; Cristophe Desterke; Vittorio Rosti; Alberto Bosi; Marie-Caroline Le Bousse-Kerdilès; Giovanni Barosi; Alessandro M Vannucchi. (2008). Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis.. STEM CELLS, vol. 26, pp. 1920-1930, ISSN:1066-5099

R. Fanci ; P. Pecile ; S. Di Lollo ; C. Dini C; A.Bosi (2008). Pulmonary mucormycosis with cervical lymph node involvement in a patient with acute myeloid leukaemia: a case report.. MYCOSES, vol. 51 (4), pp. 354-356, ISSN:0933-7407

Lisa Pieri; Paola Guglielmelli; Costanza Bogani; Alberto Bosi; Alessandro M Vannucchi; (2008). Mesenchymal stem cells from JAK2(V617F) mutant patients with primary myelofibrosis do not harbor JAK2 mutant allele.. LEUKEMIA RESEARCH, vol. 32, pp. 516-517, ISSN:0145-2126 DOI

V. Ponziani; F. Mannelli; N. Bartalucci; G. Gianfaldoni; F. Leoni; E. Antonioli; P. Guglielmelli; S. Ciolli; A. Bosi; A. M. Vannucchi (2008). No role for CXCL12-G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia.. LEUKEMIA, vol. 22, pp. 669-671, ISSN:0887-6924, Macmillan Magazines Limited:Porters South Crinian Street, London N1 9XW United Kingdom:011 44 207 8334000, 011 44 171 8434982, Fax: 011 44 207 812358: DOI

Elisabetta Antonioli; Paola Guglielmelli; Giada Poli; Costanza Bogani; Alessandro Pancrazzi; Giovanni Longo; Vanessa Ponziani; Lorenzo Tozzi; Lisa Pieri; Valeria Santini; Alberto Bosi; Alessandro M Vannucchi. (2008). Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia.. HAEMATOLOGICA, vol. 93, pp. 41-48, ISSN:0390-6078 DOI

A. Petrarca; L. Rigacci; C. Giannini; U. Arena; S. Colagrande; P. Romagnoli; R. Caporale; L. Gragnani; P. Montalto; A. Natali; A. Bosi; G. Laffi; A.L. Zignego (2008). Effects of depletion of B cell by anti-CD20 monoclonal antibody in HCV+ mixed cryoglobulinemia (MC) and liver cirrhosis. EUROPEAN JOURNAL OF INTERNAL MEDICINE, vol. 19(S1), pp. S28-S28, ISSN:0953-6205

A. Petrarca; L. Rigacci; U. Arena; F. Vizzutti; C. Giannini; P. Montalto; A. Bosi; S. Colagrande; P. Romagnoli; G. Laffi; A.L. Zignego (2008). Effect of rituximab on advanced liver disease in patients with HCV-related mixed cryoglobulinemia.. HEPATOLOGY, vol. 48, pp. 1177A-1177A, ISSN:0270-9139

C. Nozzoli; S. Guidi; M. Paglierani; E. Wnekowicz; R. Saccardi; A. Bosi; M. Santucci; D. Massi (2008). Immunohistochemical and FISH analyses identify synovitis associated with chronic GVHD after allogeneic hematopoietic SCT. BONE MARROW TRANSPLANTATION, vol. 42, pp. 289-291, ISSN:0268-3369

Ciolli S; Leoni F; Casini C; Breschi C; Santini V; Bosi A. (2008). The addition of liposomal doxorubicin to bortezomib, thalidomide and dexamethasone significantly improves clinical outcome of advanced multiple myeloma.. BRITISH JOURNAL OF HAEMATOLOGY, vol. 141, pp. 814-819, ISSN:0007-1048 DOI

F.Leoni; S. Ciolli; R. Fanci; A. Bosi (2008). BORTEZOMIB PLUS CONVENTIONAL CHEMOTHERAPY IN POOR RISK ACUTE MYELOID LEUKAEMIA: A PILOT STUDY. HAEMATOLOGICA, vol. 93, pp. 532-533, ISSN:0390-6078

Mazzanti B; Aldinucci A; Biagioli T; Barilaro A; Urbani S; Dal Pozzo S; Amato MP; Siracusa G; Crescioli C; Manuelli C; Bosi A; Saccardi R; Massacesi L; Ballerini C. (2008). Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment. JOURNAL OF NEUROIMMUNOLOGY, vol. 199, pp. 142-150, ISSN:0165-5728 DOI

Santini V.; Gozzini A.; Bosi A. (2008). Treatment options in myelodysplastic syndromes: a new frontier.. JOURNAL OF CHEMOTHERAPY, vol. 20(3), pp. 291-296, ISSN:1120-009X DOI

R. Fanci; P. Pecile; S. Di Lollo; C. Dini; A. Bosi (2008). Mucormicosi polmonare con coinvolgimento linfonodale laterocervicale in un paziente con leucemia acuta mieloide. FARMACI, vol. 32, pp. 26-28, ISSN:1122-4231

Gianfaldoni, G; Mannelli, F; Bencini, S; Leoni, F; Baldini, S; Bosi, Alberto (2008). Peripheral blood blast clearance during induction therapy in acute myeloid leukemia.. BLOOD, vol. 111, pp. 1746-1747, ISSN:0006-4971

Elisabetta Antonioli; Paola Guglielmelli; Giada Poli; Valeria Santini; Alberto Bosi; Alessandro M Vannucchi (2007). Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance.. BLOOD, vol. 110, pp. 4620-4621, ISSN:0006-4971 DOI

Coppi E; Pugliese AM; Urbani S; Melani A; Cerbai E; Mazzanti B; Bosi A; Saccardi R; Pedata F. (2007). ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells.. STEM CELLS, vol. 25, pp. 1840-1849, ISSN:1066-5099 DOI Accesso ONLINE all'editore

L. Pieri; L. Domenici; S. Urbani; G. Romano; M. Monici; R. Saccardi; V. Basile; A. Bosi; A. Aldinucci; C. Ballerini; P. Romagnoli (2007). Immunostimulatory dendritic cells can differentiate from CD133+ human cord blood cells.. ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY, vol. 112 (Suppl. 1), pp. 208-208, ISSN:1122-6714

R. Fanci ; B. Bartolozzi ; P. Pecile; D. Cecconi ; R. Mannino ; E. Casalone ; F. Donnarumma ; LA Gordiflo ; S. Sergi; S Guidi ; P. Nicoletti ; G.Mastromei ; A. Bosi (2007). Molecular epidemiological investigation of an outbreak of pseudomonas aeruginosa sepsis in stem cell transplantation patients. HAEMATOLOGICA, vol. 92, pp. 34-34, ISSN:1592-8721

Ferrari G; Pastorelli R; Buchi F; Spinelli E; Gozzini A; Bosi A; Santini V. (2007). Comparative proteomic analysis of chronic myelogenous leukemia cells: inside the mechanism of imatinib resistance.. JOURNAL OF PROTEOME RESEARCH, vol. 6, pp. 367-375, ISSN:1535-3893 DOI

Orsi, C; Bartolozzi, B; Messori, A; Bosi, Alberto (2007). Event-free survival and cost-effectiveness in adult acute lymphoblastic leukaemia in first remission treated with allogeneic transplantation. BONE MARROW TRANSPLANTATION, vol. 40, pp. 643-649, ISSN:0268-3369, Macmillan Magazines Limited:Porters South Crinian Street, London N1 9XW United Kingdom:011 44 207 8334000, 011 44 171 8434982, Fax: 011 44 207 812358:

RIGACCI L; NASSI L; PUCCIONI M; MAPPA S; POLITO E; DAL POZZO S; ALTERINI R; CARRAI V; PUCCINI B; A. BOSI (2007). Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.. ANNALS OF HEMATOLOGY, vol. 86, pp. 565-568, ISSN:0939-5555, -Springer Verlag Germany:Tiergartenstrasse 17, D 69121 Heidelberg Germany:011 49 6221 3450, EMAIL: g.braun@springer.de, INTERNET: http://www.springer.de, Fax: 011 49 6221 345229 -SPRINGER, 233 SPRING STREET, NEW YORK, USA, NY, 10013:

PIERI L; GUGLIELMELLI P; BOGANI C; A. BOSI; VANNUCCHI AM; FOR THE MYELOPROLIFERATIVE DISORDERS RESEARCH CONSORTIUM MPD-RC (2007). Mesenchymal stem cells from JAK2(V617F) mutant patients with primary myelofibrosis do not harbor JAK2 mutant allele. LEUKEMIA RESEARCH, vol. 32, pp. 516-517, ISSN:0145-2126, Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010:

Rigacci, L; Vitolo, U; Nassi, L; Merli, F; Gallamini, A; Pregno, P; Alvarez, I; Salvi, F; Sancetta, R; Castagnoli, A; Versari, A; Biggi, A; Gregianin, M; Pelosi, E; Chisesi, T; Bosi, Alberto; Levis, A; ON BEHALF OF INTERGRUPPO ITALIANO LINFOMI, (2007). Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi.. ANNALS OF HEMATOLOGY, vol. 86, pp. 897-903, ISSN:0939-5555, -Springer Verlag Germany:Tiergartenstrasse 17, D 69121 Heidelberg Germany:011 49 6221 3450, EMAIL: g.braun@springer.de, INTERNET: http://www.springer.de, Fax: 011 49 6221 345229 -SPRINGER, 233 SPRING STREET, NEW YORK, USA, NY, 10013:

CRESCENZI B; LA STARZA R; NOZZOLI C; CIOLLI S; MATTEUCCI C; ROMOLI S; RIGACCI L; GORELLO P; A. BOSI; MARTELLI MF; MARYNEN P; MECUCCI C (2007). Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic. CANCER GENETICS AND CYTOGENETICS, vol. 176, pp. 67-71, ISSN:0165-4608, Elsevier Science Incorporated / NY Journals:Madison Square Station, PO Box 882:New York, NY 10159:(212)633-3730, EMAIL: usinfo-f@elsevier.com, INTERNET: http://www.elsevier.com, Fax: (212)633-3680:

Bruno, B; Sorasio, R; Patriarca, F; Montefusco, V; Guidi, S; Busca, A; Scime, R; Console, G; Milone, G; Marotta, G; Dominietto, A; Giaccone, L; Rotta, M; Falda, M; Bacigalupo, A; Bosi, Alberto; Corradini, P; Fanin, R; Pollichieni, S; Gitmo, BOCCADORO M. (2007). Unrelated donor haemato- poietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma.. EUROPEAN JOURNAL OF HAEMATOLOGY, vol. 78, pp. 330-337, ISSN:0902-4441, Blackwell Munksgaard:PO Box 2148, Periodicals Department, DK-1016 Copenhagen K Denmark:011 45 33 755913, EMAIL: agentservices@oxon.blackwellpublishing.com, INTERNET: http://www.blackwellmunksgaard.com, Fax: 011 45 77 333377:

RIGACCI L; MAPPA S; NASSI L; ALTERINI R; CARRAI V; BERNARDI F; A. BOSI (2007). Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines.. HEMATOLOGICAL ONCOLOGY, vol. 25, pp. 198-203, ISSN:0278-0232, John Wiley & Sons Limited:1 Oldlands Way, Bognor Regis, P022 9SA United Kingdom:011 44 1243 779777, EMAIL: cs-journals@wiley.co.uk, INTERNET: http://www.wiley.co.uk, Fax: 011 44 1243 843232:

E. Portaccio; M. P. Amato; G. Siracusa; F. Pagliai; S. Sorbi; S. Guidi; A. Bosi; R. Saccardi (2007). Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases.. MULTIPLE SCLEROSIS, vol. 13, pp. 676-678, ISSN:1352-4585

B. Bartolozzi; R. Fanci ; P. Pecile; D. Cecconi ; R. Mannino; E.Casalone; F. Donnarumma ; A. Gordillo Leon ; S. Sergi ; S. Guidi; P. Nicoletti; G. Mastromei; A. Bosi (2007). Microbiologic survey with biotyping methods in haematological patients.. HAEMATOLOGICA, vol. 92, pp. 36-36, ISSN:1592-8721

R. Fanci; B. Bartolozzi; C. Casini ; G. Longo ; A. Bosi (2007). Piperacillin-tazobactam monotherapy as management of febrile neutropenia in patients with acute leukemia; a monocentric experience. HAEMATOLOGICA, vol. 92, pp. 155-155, ISSN:1592-8721

BARTOLOZZI B; A. BOSI; ORSI C (2007). Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis. CANCER, vol. 109, pp. 343-344, ISSN:0008-543X, John Wiley & Sons Incorporated:Customer Service, 111 River Street:Hoboken, NJ 07030:(800)225-5945, (201)748-6000, EMAIL: societyinfo@wiley.com, INTERNET: http://www.wiley.com, Fax: (212)748-6551:

ZAJA F; BACIGALUPO A; PATRIARCA F; STANZANI M; VAN LINT MT; FILI C; SCIME R; MILONE G; FALDA M; VENER C; LASZLO D; ALESSANDRINO PE; NARNI F; SICA S; OLIVIERI A; SPEROTTO A; A. BOSI; BONIFAZI F; FANIN R (2007). Treatment of refractory chronic GVHD with Rituximab: a GITMO study.. BONE MARROW TRANSPLANTATION, vol. 40, pp. 273-277, ISSN:0268-3369, Macmillan Magazines Limited:Porters South Crinian Street, London N1 9XW United Kingdom:011 44 207 8334000, 011 44 171 8434982, Fax: 011 44 207 812358:

GORI E; ARPINATI M; BONIFAZI F; ERRICO A; MEGA A; ALBERANI F; SABBI V; COSTAZZA G; LEANZA S; BORRELLI C; BERNI M; FERAUT C; POLATO E; ALTIERI MC; PIROLA E; LODDO MC; BANFI M; BARZETTI L; CALZA S; BRIGNOLI C; BANDINI G; DE VIVO A; A. BOSI; BACCARANI M (2007). Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. BONE MARROW TRANSPLANTATION, vol. 39, pp. 347-352, ISSN:0268-3369, Macmillan Magazines Limited:Porters South Crinian Street, London N1 9XW United Kingdom:011 44 207 8334000, 011 44 171 8434982, Fax: 011 44 207 812358:

RIGACCI L; NASSI L; ALTERINI R; CARRAI V; LONGO G; BERNARDI F; MARTINI V; A. BOSI (2007). Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study.. ACTA HAEMATOLOGICA, vol. 115, pp. 22-27, ISSN:0001-5792, S Karger AG:Allschwilerstrasse 10, CH-4009 Basel Switzerland:011 41 61 3061111, EMAIL: orders@karger.ch, INTERNET: http://www.karger.com, Fax: 011 41 61 3061234:

A. Petrarca; L. Rigacci; M. Monti; C. Giannini; F. Bernardi; P. Caini; S. Colagrande ; A. Bosi; G. Laffi; A.L. Zignego (2007). Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab. DIGESTIVE AND LIVER DISEASE, vol. 39 S1, pp. 129-133, ISSN:1590-8658 DOI

A. Petrarca; L. Rigacci; C. Giannini; R. Caporale; P. Montalto; A. Bosi; G. Laffi; A.L. Zignego (2007). Can depletion of B-cells by anti-CD20 monoclonal antibody in HCV plus mixed cryoglobulinemia (MC) improve liver cirrhosis?. JOURNAL OF HEPATOLOGY, vol. 46, pp. S238-S238, ISSN:0168-8278

A. M. Vannucchi; E. Antonioli; P. Guglielmelli; G. Longo; A. Pancrazzi; V. Ponziani; C. Bogani; P. R. Ferrini; A. Rambaldi; V. Guerini; A. Bosi; T. Barbui. (2007). Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden.. LEUKEMIA, vol. 21, pp. 1952-1959, ISSN:0887-6924 DOI

Paola Guglielmelli; Alessandro Pancrazzi; Gaetano Bergamaschi; Vittorio Rosti; Laura Villani; Elisabetta Antonioli; Alberto Bosi; Giovanni Barosi; Alessandro M Vannucchi; (2007). Anaemia characterises patients with myelofibrosis harbouring Mpl mutation.. BRITISH JOURNAL OF HAEMATOLOGY, vol. 137, pp. 244-247, ISSN:0007-1048 DOI

Paola Guglielmelli; Lorenzo Tozzi; Alessandro Pancrazzi; Costanza Bogani; Elisabetta Antonioli; Vanessa Ponziani; Giada Poli; Roberta Zini; Sergio Ferrari; Rossella Manfredini; Alberto Bosi; Alessandro M Vannucchi. (2007). MicroRNA expression profile in granulocytes from primary myelofibrosis patients.. EXPERIMENTAL HEMATOLOGY, vol. 35, pp. 1708-1718, ISSN:0301-472X DOI

Monica Bocchia; Alessandro M Vannucchi; Alessandro Gozzetti; Paola Guglielmelli; Giada Poli; Rosaria Crupi; Marzia Defina; Alberto Bosi; Lauria Francesco (2007). Insights into JAK2-V617F mutation in CML.. THE LANCET ONCOLOGY, vol. 8, pp. 864-866, ISSN:1470-2045 DOI

Costanza Bogani; Paola Guglielmelli; Elisabetta Antonioli; Alessandro Pancrazzi; Alberto Bosi; Alessandro Maria Vannucchi (2007). B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis.. HAEMATOLOGICA, vol. 92, pp. 258-259, ISSN:0390-6078 DOI

A. M. Vannucchi; S. Guidi; P. Guglielmelli; S. Glinz; L. Lombardini; A. Busca; F. Locatelli; A. M. Dall'Omo; A. Bosi (2007). Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation.. BONE MARROW TRANSPLANTATION, vol. 40, pp. 1001-1002, ISSN:0268-3369 DOI

R.FANCI; B.BARTOLOZZI; P.PECILE; D.CECCONI; R.MANNINO; E.CASALONE; A.GORDILLO LEON; S.SERGI; S.GUIDI; P.NICOLETTI; G.MASTROMEI; A.BOSI (2007). AFLP epidemiological investigation of an outbreak of Pseudomonas aeruginosa sepsis in stem cell transplantation patients. BONE MARROW TRANSPLANTATION, vol. 39, pp. 168-169, ISSN:0268-3369

Alessandro M Vannucchi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro Rambaldi; Giovanni Barosi; Roberto Marchioli; Rosa Maria Marfisi; Guido Finazzi; Vittoria Guerini; Fabrizio Fabris; Maria Luigia Randi; Valerio De Stefano; Sabrina Caberlon; Agostino Tafuri; Marco Ruggeri; Giorgina Specchia; Vincenzo Liso; Edoardo Rossi; Enrico Pogliani; Luigi Gugliotta; Alberto Bosi; Tiziano Barbui (2007). Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.. BLOOD, vol. 110, pp. 840-846, ISSN:0006-4971

Paola Guglielmelli; Roberta Zini; Costanza Bogani; Simona Salati; Alessandro Pancrazzi; Elisa Bianchi; Francesco Mannelli; Sergio Ferrari; Marie-Caroline Le Bousse-Kerdilès; Alberto Bosi; Giovanni Barosi; Anna Rita Migliaccio; Rossella Manfredini; Alessandro M Vannucchi (2007). Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1).. STEM CELLS, vol. 25, pp. 165-173, ISSN:1066-5099 DOI

Nozzoli C; Bartolozzi B; Guidi S; Orsi A; Vannucchi AM; Leoni F; Bosi A. (2006). Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation.. LEUKEMIA & LYMPHOMA, vol. 47(1), pp. 167-169, ISSN:1042-8194

R Fanci ; P Pecile ; E Casalone ; A Mengoni ; E Tamburini ; S Guidi ; D Cecconi ; A Bosi ; P Nicoletti ; G Mastromei . (2006). Pseudomonas aeruginosa sepsis in stem cell transplantation patients.. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, vol. 27, pp. 767-770, ISSN:0899-823X DOI Accesso ONLINE all'editore

CIOLLI S; LEONI F; GIGLI F; RIGACCI L; A. BOSI (2006). Low dose Velcade, thalidomide and dexamethasone (LD-VTD): an effective regimen for relapsed and refractory multiple myeloma patients.. LEUKEMIA & LYMPHOMA, vol. 47, pp. 171-173, ISSN:1042-8194, Taylor & Francis Limited:Rankine Road, Basingstoke RG24 8PR United Kingdom:011 44 1256 813035, EMAIL: madeline.sims@tandf.co.uk, info@tandf.co.uk, INTERNET: http://www.tandf.co.uk, Fax: 011 44 1256 330245:

BACIGALUPO A; LAMPARELLI T; BARISIONE G; BRUZZI P; GUIDI S; ALESSANDRINO PE; DI BARTOLOMEO P; ONETO R; BRUNO B; SACCHI N; VAN LINT MT; A. BOSI (2006). Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 12, pp. 560-565, ISSN:1083-8791

Bartolozzi, B; Nozzoli, C; Pandolfo, C; Antonioli, E; Guizzardi, G; Morichi, R; Bosi, Alberto (2006). Percutaneous vertebroplasty and kyphoplasty in patients with multiple myeloma. EUROPEAN JOURNAL OF HAEMATOLOGY, vol. 76, pp. 180-181, ISSN:0902-4441, Blackwell Munksgaard:PO Box 2148, Periodicals Department, DK-1016 Copenhagen K Denmark:011 45 33 755913, EMAIL: agentservices@oxon.blackwellpublishing.com, INTERNET: http://www.blackwellmunksgaard.com, Fax: 011 45 77 333377:

G.TALIANI ; A.TOZZI ; R. FANCI; E.BILIOTTI ; A. BOSI (2006). Fatal acute hepatitis C virus infection in patients with hematological malignancies.. JOURNAL OF CHEMOTHERAPY, vol. 18, pp. 662-664, ISSN:1120-009X, ESIFT Srl:Casella Postale 147, I 50018 Scandicci Fi Italy:011 39 055 4271516, EMAIL: mary@jchemother.it, Fax: 011 39 055 4271280:

Urbani, S.; Caporale, R.; Lombardini, L.; Bosi, Alberto; Saccardi, R. (2006). Use of CFDA-SE for evaluating the in vitro proliferation pattern of human mesenchymal stem cells.. CYTOTHERAPY, vol. 8, pp. 243-253, ISSN:1465-3249, Editore attuale: TAYLOR & FRANCIS AS, CORT ADELERSGT 17, PO BOX 2562, SOLLI, OSLO, NORWAY, 0202 precedente: Martin Dunitz Limited:The Livery House, 7-9 Pratt Street, London NW1 0AE United Kingdom:011 44 20 74822202, INTERNET: http://www.dunitz.co.uk, Fax: 011 44 20 72670159:

A. M. Vannucchi;P. Guglielmelli;E. Antonioli;S. Mappa;A. Pancrazzi;C. Bogani;V. Ponziani;A. Bosi (2006). Inconsistencies in the association between the JAK2(V617F) mutation and PRV-1 over-expression among the chronic myeloproliferative diseases.. BRITISH JOURNAL OF HAEMATOLOGY, vol. 132, pp. 652-4; author reply 654, ISSN:0007-1048 DOI Accesso ONLINE all'editore

V. Ponziani;G. Gianfaldoni;F. Mannelli;F. Leoni;S. Ciolli;P. Guglielmelli;E. Antonioli;G. Longo;A. Bosi;A. M. Vannucchi (2006). The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients.. LEUKEMIA, vol. 20, pp. 2074-2076, ISSN:0887-6924 DOI Accesso ONLINE all'editore

Vannucchi, A.; Guglielmelli, P.; Antonioli, E.; Mappa, S.; Pancrazzi, A.; Bogani, C.; Ponziani, V.; Bosi, A. (2006). Inconsistencies in the association between the JAL2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseases. BRITISH JOURNAL OF HAEMATOLOGY, vol. 132, pp. 651-654, ISSN:0007-1048

Ponziani V; Porfirio B; Guglielminelli P; Poli G; Guidi S; Nozzoli C; Lombardini L; Vannucchi AM; Bosi A. (2006). Development of a quantitative real time PCR assay for chimerism monitoring after sex-mismatched stem cell transplantation. Haematologica 91(s3) 2006, p. 20.. HAEMATOLOGICA, pp. 20-20, ISSN:0390-6078

GIANFALDONI G; MANNELLI F; M. BACCINI; ANTONIOLI E; LEONI F; BOSI A (2006). Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study.. BRITISH JOURNAL OF HAEMATOLOGY, vol. 134, pp. 54-57, ISSN:0007-1048

GALLAMINI A; RIGACCI L; MERLI F; NASSI L; A. BOSI; CAPODANNO I; LUMINARI S; VITOLO U; SANCETTA R; IANNITTO E; TRENTIN L; STELITANO C; TAVERA S; BIGGI A; CASTAGNOLI A; VERSARI A; GREGIANIN M; PELOSI E; TORCHIO P; LEVIS A. (2006). The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. HAEMATOLOGICA, vol. 91, pp. 475-481, ISSN:0390-6078, Fondaz Ferrata Storti:Strada Nuova 134, 27100 Pavia Italy:011 39 0382 531182, EMAIL: office@haematologica.it, Fax: 011 39 0382 27721:

Vannucchi, ALESSANDRO MARIA; Ficarra, G.; Antonioli, E.; Bosi, Alberto (2005). Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma.. BRITISH JOURNAL OF HAEMATOLOGY, vol. 128, pp. 738-738, ISSN:0007-1048

Rigacci, L; Castagnoli, A; Dini, C; Carpaneto, A; Matteini, M; Alterini, R; Carrai, V; Nassi, L; Bernardi, F; Pieroni, C; Bosi, Alberto (2005). 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.. ONCOLOGY REPORTS, vol. 14, pp. 1209-1214, ISSN:1021-335X, Editore attuale: PROFESSOR D A SPANDIDOS, 1, S MERKOURI ST, EDITORIAL OFFICE,, ATHENS, GREECE, 116 35 PRECEDENTE: National Hellenic Research Foundation:48 Vas Constatinou Avenue, Athens 11635 Greece:011 30 1 7241505, Fax: 011 30 1 7241505:

Bosi, Alberto; Bartolozzi, B; Guidi, S. (2005). Allogeneic stem cell transplantation. TRANSPLANTATION PROCEEDINGS, vol. 37, pp. 2667-2669, ISSN:0041-1345, Elsevier Science Incorporated / NY Journals:Madison Square Station, PO Box 882:New York, NY 10159:(212)633-3730, EMAIL: usinfo-f@elsevier.com, INTERNET: http://www.elsevier.com, Fax: (212)633-3680:

Miniati I;Saccardi R;Pagliai F;Guiducci S;Bosi A;Guidi S;Urbani S;Tyndall A;Matucci Cerinic M (2005). [The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases].. REUMATISMO, vol. 57, pp. 277-282, ISSN:0048-7449

Antonioli, E; Nozzoli, C; Gianfaldoni, G; Mannelli, F; Rossi, S; Betti, S; Bernardeschi, P; Fiorentini, G; Bosi, Alberto (2005). Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma. ANNALS OF ONCOLOGY, vol. 16, pp. 1849-1850, ISSN:0923-7534, Attuale:OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP Kluwer Academic Publishers:Journals Department, PO Box 322, 3300 AH Dordrecht Netherlands:011 31 78 6576050, EMAIL: frontoffice@wkap.nl, kluweronline@wkap.nl, INTERNET: http://www.kluwerlaw.com, Fax: 011 31 78 6576254:

R.Fanci; C. Casini; F. Leoni; M. Bonolis; A. Bosi (2005). Nosocomial infections in acute leukemia:comparison between younger and elderly patients. HAEMATOLOGICA, vol. 90 ( suppl 3), pp. 92-93, ISSN:0390-6078

R. FANCI; GUIDI S; BONOLIS M; BOSI A (2005). Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with Caspofungin. BONE MARROW TRANSPLANTATION, vol. 35, pp. 1215-1216, ISSN:0268-3369, Macmillan Magazines Limited:Porters South Crinian Street, London N1 9XW United Kingdom:011 44 207 8334000, 011 44 171 8434982, Fax: 011 44 207 812358:

SACCARDI R; MANCARDI GL; SOLARI A; BOSI A; BRUZZI P; DI BARTOLOMEO P; DONELLI A; FILIPPI M; GUERRASIO A; GUALANDI F; LA NASA G; MURIALDO A; PAGLIAI F; PAPINESCHI F; SCAPPINI B; MARMONT AM; AND THE ITALIAN GITMO-NEURO INTERGROUP ON AUTOLOGOUS HEMOTOPOIETIC STEM CELL TRANSPLANTATION; L. MASSACESI (2005). Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.. BLOOD, vol. 105, pp. 2601-2607, ISSN:0006-4971

A. BOSI (2005). THE TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS WITH AUTOLOGOUS HEMOPOIETIC STEM CELLS TRANSPLANTATION (HSCT): OUR EXPERIENCE ON 2 CASES. MULTIPLE SCLEROSIS, vol. 13, pp. 676-678, ISSN:1352-4585

RIGACCI L; CARRAI V; NASSI L; ALTERINI R; LONGO G; BERNARDI F; A. BOSI (2005). Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma.. CANCER, vol. 103, pp. 970-977, ISSN:0008-543X

E. ANTONIOLI; A. VANNUCCHI; A. BOSI; G. GIANFALDONI; F. MANNELLI (2005). Chronic relapsing thrombotic thrombocytopenic purpura succesfully treated with rituximab: case report. JOURNAL OF CHEMOTHERAPY, vol. 17, pp. 449-451, ISSN:1120-009X

P. Romagnani; E. Lazzeri; B. Mazzinghi; L. Lasagni; S. Guidi; A. Bosi; C. Cirami; M. Salvadori (2005). Nephrotic syndrome and renal failure after allogeneic stem cell transplantation: Novel molecular diagnostic tools for a challenging differential diagnosis. AMERICAN JOURNAL OF KIDNEY DISEASES, vol. 46, pp. 550-556, ISSN:0272-6386 DOI

PAGANO L; PULSONI A; VIGNETTI M; TOSTI ME; FALCUCCI P; FAZI P; FIANCHI L; LEVIS A; A. BOSI; ANGELUCCI E; BREGNI M; GABBAS A; PETA A; COSER P; RICCIUTI F; MORSELLI M; CAIRA M; FOA R; AMADORI S; MANDELLI F; LEONE G. (2005). SECONDARY ACUTE MYELOID LEUKAEMIA: RESULTS OF CONVENTIONAL TREATMENTS. EXPERIENCE OF GIMEMA TRIALS.. ANNALS OF ONCOLOGY, vol. 16, pp. 228-233, ISSN:0923-7534

A. M. Vannucchi;A. Pancrazzi;P. Guglielmelli;S. D. Lollo;C. Bogani;G. Baroni;L. Bianchi;A. R. Migliaccio;A. Bosi;F. Paoletti (2005). Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.. THE AMERICAN JOURNAL OF PATHOLOGY, vol. 167, pp. 849-858, ISSN:0002-9440 DOI Accesso ONLINE all'editore

Antonioli E; Guglielmelli P; Pancrazzi A; Bogani C; Verrucci M; Ponziani V; Longo G; Bosi A; Vannucchi AM. (2005). Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.. LEUKEMIA, vol. 19(10), pp. 1847-1849, ISSN:0887-6924 DOI Accesso ONLINE all'editore

P. Rubegni;A. Cuccia;P. Sbano;G. Cevenini;M. R. Carcagnì;G. D'Ascenzo;G. D. Aloe;S. Guidi;P. Guglielmelli;P, Marotta;F. Lauria;A. Bosi;M. Fimiani (2005). Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.. BRITISH JOURNAL OF HAEMATOLOGY, vol. 130, pp. 271-275, ISSN:0007-1048 DOI Accesso ONLINE all'editore

Gianfaldoni, G; Antonioli, E; Mannelli, F; Vannucchi, Am; Bosi, A. (2005). Chronic relapsing thrombotic thrombocytopenic purpura successfully treated with rituximab: case report.. JOURNAL OF CHEMOTHERAPY, pp. 449-451, ISSN:1973-9478

ROCHA V; LABOPIN M; SANZ G; ARCESE W; SCHWERDTFEGER R; A. BOSI; JACOBSEN N; RUUTU T; DE LIMA M; FINKE J; FRASSONI F; GLUCKMAN E. (2004). Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leucemia.. THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 351, pp. 2276-2285, ISSN:0028-4793

CIOLLI S; A. VANNUCCHI; LEONI F; NOZZOLI C; LONGO G; SALATI A; PANCRAZZI A; BIANCHI L; BOSI A; ROSSI FERRINI P. (2004). Internal tandem duplication of FLT3 gene (FLT3/TID) predicts a poor post-remission outcome in adult patients witha cute non-promyelocytic leukemia. LEUKEMIA & LYMPHOMA, vol. 45, pp. 73-78, ISSN:1042-8194

E. CASALONE; G. MASTROMEI; A. MENGONI; A. BOSI; D. CECCONI; R. FANCI; S. GUIDI; P. NICOLETTI; P. PECILE (2004). MOLECULAR EPIDEMIOLOGY BY AFLP ANALYSIS OF PSEUDOMONAS AERUGINOSA STRAINS FROM BONE MARROW TRANSPLANTATION PATIENTS AND HOSPITAL ENVIRONMENT. In: INTERNATIONAL CONGRESS AMERICAN SOCIETY MICROBIOLOGY, NEW ORLEANS, international, pp. 10-20.

R. FANCI; CASINI C; LEONI F; CIOLLI S; BOSI A (2004). Incidence and management of proven and probable fungal infections in patients with acute leukemia: a single center experience.. JOURNAL OF CHEMOTHERAPY, vol. 16, pp. 557-560, ISSN:1120-009X, ESIFT Srl:Casella Postale 147, I 50018 Scandicci Fi Italy:011 39 055 4271516, EMAIL: mary@jchemother.it, Fax: 011 39 055 4271280:

A. M. Vannucchi;A. Grossi;A. Pancrazzi;E. Antonioli;P. Guglielmelli;F. Balestri;M. Biscardi;S. Bulgarelli;G. Longo;C. Graziano;L. Gugliotta;A. Bosi (2004). PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia.. BRITISH JOURNAL OF HAEMATOLOGY, vol. 127, pp. 214-219, ISSN:0007-1048 DOI Accesso ONLINE all'editore

R.FANCI; S.GUIDI; P.PECILE; P.NICOLETTI; E.CASALONE; A.MENGONI; G.MASTROMEI; A.BOSI (2003). Molecular epidemiology of Pseudomonas aeruginosa with amplified fragment length polymorphism in stem cell transplantation patients. HAEMATOLOGICA, vol. 88, pp. 125-125, ISSN:0390-6078

R. FANCI; C. CASINI RAGGI; F. LEONI; C. PACI; A. BOSI (2003). ANTIFUNGAL STRATEGIES IN ACUTE LEUKEMIC PATIENTS WITH PERSISTENT FEBRILE NEUTROPENIA. HAEMATOLOGICA, vol. 88 (suppl n 15), pp. 372-372, ISSN:0390-6078

Bosi, Alberto (2003). PET SCAN EVALUATION OF THYMIC MASS AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM-CELL TRANSPLANTATION IN AN ADULT WITH NON-HODGKIN'S LYMPHOMA. LEUKEMIA & LYMPHOMA, vol. 44, pp. 2015-2018, ISSN:1042-8194

S. Ciolli ; F. Gigli; F. Mannelli ; R. Fanci ; A. Grossi ; G. Longo ; L. Rigacci ; A. Bosi (2003). High response rates and reduced first dose reactions with subcutaneous alemtuzumab in patients with relapsed and refractory CLL. BLOOD, vol. 102, pp. 357B-358B, ISSN:0006-4971

Bosi, Alberto (2003). HIGH RATE OF REMISSION AND LOW RATE OF DISEASE RECURRENCE IN PATIENTS WITH MULTIPLE MYELOMA ALLOGRAFTED WITH PBSC FROM THEIR HLA-IDENTICAL SIBLING DONORS.. BONE MARROW TRANSPLANTATION, vol. 31, pp. 767-773, ISSN:0268-3369

A. BOSI (2003). CIDOFOVIR FOR ADENOVIRUS INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A SURVEY BY THE INFECTIOUS DISEASES WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION.. BONE MARROW TRANSPLANTATION, vol. 31, pp. 481-486, ISSN:0268-3369

A. BOSI (2003). TREATMENT OF LARGE CELL LYMPHOMA IN ELDERLY PATIENTS WITH A MITOXANTRONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, AND PREDNISONE REGIMEN: LONG-TERM FOLLOW-UP RESULTS.. CANCER, vol. 97, pp. 97-104, ISSN:0008-543X

Bosi, Alberto (2003). IMPACT OF MARROW UNRELATED DONOR SEARCH DURATION ON OUTCOME OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN SECOND REMISSION. BONE MARROW TRANSPLANTATION, vol. 32, pp. 325-331, ISSN:0268-3369

A. TOZZI; R. FANCI; F. LEONI; A. BOSI; G. TALIANI (2003). ACUTE HEPATITIS C VIRUS INFECTION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES. HAEMATOLOGICA, vol. 88 ( suppl 15), pp. 376-376, ISSN:0390-6078

S. CIOLLI; F. GIGLI; R. FANCI; A. GROSSI; G. LONGO; L. RIGACCI; A. BOSI; F. MANNELLI (2003). SUBCUTANEOUS CAMPATH-1H IN REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA: FEASIBILITY AND EFFICACY. In: XXXIX CONGRESSO SOCIETA' ITALIANA DI EMATOLOGIA, ROMA, SIE, pp. 10-11.

S. GUIDI; R. FANCI; A. BOSI; E. CASALONE; A. MENGONI; G. MASTROMEI; P. PECILE; P. NICOLETTI; D. CECCONI (2003). EPIDEMIOLOGIA MOLECOLARE CON AFLP DI P. AERUGINOSA ISOLATI DA PAZIENTI TRAPINTATI DI MIDOLLO OSSEO. In: CONGRESSO NAZIONALE AMCLI, SIE, pp. 10-11.

RUUTU T; HERMANS J; NIEDERWIESER D; GRATWOHL A; KHIEL M; VOLIN L; BERTZ H; LJUNGMAN P; SPENCE D; VERDONK LF; PRENTICE HG; A. BOSI (2002). THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A SURVEY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (EBMT). BRITISH JOURNAL OF HAEMATOLOGY, vol. 118, pp. 1112-1119, ISSN:0007-1048, Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: journals.cs@blacksci.co.uk, INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205:

A. BOSI; B. BARTOLOZZI; R. FANCI; P. ROSSI FERRINI (2002). THERAPY OF INFECTIONS IN HAEMATOLOGICAL MALIGNANCIES. In: FOURTH INTERNATIONAL MEETING ON THE THERAPY OF INFECTIONS, FIRENZE, IT, pp. 0-0.

Bosi A; Bartolozzi B; Vannucchi AM; Orsi A; Guidi S; Rossi Ferrini P. (2002). Polymerase chain reaction-based "pre-emptive" therapy with cidofovir for cytomegalovirus reactivation in allogeneic hematopoietic stem cells transplantation recipients: a prospective study.. HAEMATOLOGICA, vol. 87(4), pp. 446-447, ISSN:0390-6078

A. BOSI; LASZLO; LABOPIN M; REIFFERS J; GLUCKMAN E (2001). SECOND ALLOGENEIC BONE MARROW TRANSPLANTATION IN ACUTE LEUKEMIA:RESULTS OF A SURVEY BY THE EUROPEAN COOPERATIVE GROUP FOR BLOOD AND MARROW TRANSPLANTATION. JOURNAL OF CLINICAL ONCOLOGY, vol. 19, pp. 3675-3685, ISSN:0732-183X, editori attuale: -American Society of Clinical Oncology. , 330 JOHN CARLYLE ST, STE 300, ALEXANDRIA, USA, VA, 22314 precedente: -W B Saunders Company:Fulfillment Department, The Curtis Center, Independence Square West:Philadelphia, PA 19106:(800)654-2452, (215)238-7800, EMAIL: wbspcs@harcourt.com, INTERNET: http://elsevierhealth.com, Fax: (215)238-6445:

F. LEONI; R. FANCI; S. CIOLLI; C. NOZZOLI; A. BOSI; P. ROSSI FERRINI; G. GIANFALDONI; F. FERRARA (2001). ARSENIC TRIOXIDE THERAPY FOR RELAPSED ACUTE PROMIELOCYTIC LEUKEMIA: AN USEFUL BRIDGE TO TRANSPLANTION. In: 38° CONGRESSO NAZIONALE SIE, FIRENZE, SIE, pp. 20-30.

Dini, G; Cancedda, R; Locatelli, F; Bosi, Alberto (2001). UNRELATED DONOR MARROW TRANSPLANTATION:AN UPDATE OF THE EXPERIENCE OF THE ITALIAN BONE MARROW TRANSPLANT GROUP (GITMO). HAEMATOLOGICA, vol. 86, pp. 451-456, ISSN:0390-6078, Fondaz Ferrata Storti:Strada Nuova 134, 27100 Pavia Italy:011 39 0382 531182, EMAIL: office@haematologica.it, Fax: 011 39 0382 27721:

Bacigalupo, A; Lamparelli, T; Bruzzi, P; Guidi, S; Alessandrino, Pe; BARTOLOMEO P, Di; Oneto, R; Bruno, B; Barbanti, M; Sacchi, N; Van, LINT MT; Bosi, Alberto (2001). ANTITHYMOCYTE GLOBULIN FOR GRAFT.VERSUS-HOST DISEASE PROPHYLAXIS IN TRANSPLANTS FROM UNRELATED DONORS: 2 RANDOMIZED STUDIES FROM GRUPPO ITALIANO TRAPIANTI DI MIDOLLO OSSEO. BLOOD, vol. 98, pp. 2942-2947, ISSN:0006-4971, American Society of Hematology:1900 M Street Northwest, Suite 200:Washington, DC 20036:(800)633-4931, (202)776-0544, EMAIL: publishing@hematology.org, ash@hematology.org, INTERNET: http://www.hematology.org, Fax: (202)776-0551:

A. VANNUCCHI; GLINZ S; BOSI A; CAPORALE R; ROSSI FERRINI P (2001). Selective ex vivo expansion of cytomegalovirus/specific CD4 and CD8 T lymphocytes using dendritic cells pulsed with a human leukocyte antigen A201 restricted peptide. BRITISH JOURNAL OF HAEMATOLOGY, vol. 113, pp. 479-482, ISSN:0007-1048

A. BOSI (2000). NO IMPACT OF HIGH-DOSE CYTARABINE ON THE OUTCOME OF PATIENTS TRANSPLANTED FOR ACUTE MYELOBLASTIC LEUKAEMIA IN FIRST REMISSION. ACUTE LEUKAEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (EBMT).. BRITISH JOURNAL OF HAEMATOLOGY, vol. 110, pp. 308-314, ISSN:0007-1048

A. Azzi; S.Cesaro; D. Laszlo; K. Zakrzewska; S. Ciappi; R. De Santis; R. Fanci; G. Pesavento; E. Calore; A. Bosi (1999). Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow tranplantation patients. JOURNAL OF MEDICAL VIROLOGY, vol. 14, pp. 79-96, ISSN:0146-6615

Messori, A; Bosi, Alberto; Bacci, S; Laszlo, D; Trippoli, S; Locatelli, F; Van Lint, Mt; Di Bartolomeo, P; Amici, A. (1999). Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Gruppo Italiano Trapianto di Midollo Osseo.. BONE MARROW TRANSPLANTATION, pp. 489-495, ISSN:1476-5365

Iacopino, P; Pucci, G; Arcese, W; Bosi, A; Falda, M; Locatelli, F; Marenco, P; Miniero, R; Morabito, F; Rossetti, F; Sica, S; Uderzo, C; Bacigalupo, A. (1999). Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO).. BONE MARROW TRANSPLANTATION, pp. 47-51, ISSN:1476-5365

A. Bosi; D. Laszlo; S. Bacci; R. Fanci; S. Guidi; R. Saccardi; A. M. Vannucchi; P. Rossi-Ferrini (1999). An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.. JOURNAL OF CHEMOTHERAPY, vol. 11, pp. 287-292, ISSN:1120-009X

Massi, D; Franchi, A; Pimpinelli, N; Laszlo, D; Bosi, Alberto; Santucci, M. (1999). A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease.. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, pp. 791-800, ISSN:0002-9173

A. M. Vannucchi; S. Glinz; A. Bosi; C. Fallai; P. Rossi-Ferrini (1999). Detection of contaminating tumor cells by RT-PCR in breast cancer patients.. BONE MARROW TRANSPLANTATION, vol. 24, pp. 228-229, ISSN:0268-3369

MASSI D.; FRANCHI A.; PIMPINELLI N.; LASZLO D.; BOSI A.; M. SANTUCCI (1999). A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, vol. 112, pp. 791-800, ISSN:0002-9173

A. AZZI; CESARO S; LASZLO D; ZAKRZEWSKA K; CIAPPI S; DE SANTIS R; FANCI R; PESAVENTO G; CALORE E; BOSI A. (1999). Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients.. JOURNAL OF CLINICAL VIROLOGY, vol. 14, pp. 79-86, ISSN:1386-6532, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598:

Van Lint, Mt; Uderzo, C; Locasciulli, A; Majolino, I; Scimé, R; Locatelli, F; Giorgiani, G; Arcese, W; Iori, Ap; Falda, M; Bosi, A; Miniero, R; Alessandrino, P; Dini, G; Rotoli, B; Bacigalupo, A. (1998). Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.. BLOOD, pp. 2288-2293, ISSN:1528-0020

Dini, G; Arcese, W; Barbanti, M; Biffoni, F; Bosi, Alberto; Lanino, E; Majolino, I; Menichella, G; Reali, G. (1998). Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant.. BONE MARROW TRANSPLANTATION, pp. 41-45, ISSN:1476-5365

Carreras, E; Bertz, H; Arcese, W; Vernant, Jp; Tomás, Jf; Hagglund, H; Bandini, G; Esperou, H; Russell, J; de la Rubia, J; Di Girolamo, G; Demuynck, H; Hartmann, O; Clausen, J; Ruutu, T; Leblond, V; Iriondo, A; Bosi, Alberto; Ben Bassat, I; Koza, V; Gratwohl, A; Apperley, J. f. (1998). incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.. BLOOD, pp. 3599-3604, ISSN:1528-0020

A. Bosi; M. Zazzi; A. Amantini; M. Cellerini; A. M. Vannucchi; A. De Milito; S. Guidi; R. Saccardi; L. Lombardini; D. Laszlo; P. Rossi Ferrini (1998). Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant.. BONE MARROW TRANSPLANTATION, vol. 22, pp. 285-288, ISSN:0268-3369

Ljungman, P; Cordonnier, C; Einsele, H; Bender Götze, C; Bosi, Alberto; Dekker, A; De la Camara, R; Gmür, J; Newland, Ac; Prentice, Hg; Robinson, Aj; Rovira, M; Rösler, W; Veil, D. (1998). Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT). Infectious Diseases Working Party of the EBMT.. BONE MARROW TRANSPLANTATION, pp. 473-476, ISSN:0268-3369

A. M. Vannucchi; A. Bosi; S. Glinz; P. Pacini; S. Linari; R. Saccardi; R. Alterini; L. Rigacci; S. Guidi; L. Lombardini; G. Longo; M. P. Mariani; P. Rossi-Ferrini (1998). Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA.. BRITISH JOURNAL OF HAEMATOLOGY, vol. 103, pp. 610-617, ISSN:0007-1048

A. M. Vannucchi; A. Bosi; S. Linari; S. Guidi; G. Longo; L. Lombardini; M. P. Mariani; R. Saccardi; D. Laszlo; P. Rossi Ferrini (1997). High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.. HAEMATOLOGICA, vol. 82, pp. 53-56, ISSN:0390-6078

Mencucci, R; Rossi Ferrini, C; Bosi, A; Volpe, R; Guidi, S; Salvi, G. (1997). Ophthalmological aspects in allogenic bone marrow transplantation: Sjögren-like syndrome in graft-versus-host disease.. EUROPEAN JOURNAL OF OPHTHALMOLOGY, pp. 13-18, ISSN:1120-6721

Bosi, A; Bacci, S; Miniero, R; Locatelli, F; Laszlo, D; Longo, G; Busca, A; Van Lint, Mt; Di Bartolomeo, P; Amici, A. (1997). Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO).. LEUKEMIA, pp. 420-424, ISSN:1476-5551

D. Laszlo; S. Bacci; A. Bosi; R. Fanci; S. Guidi; R. Saccardi; A. M. Vannucchi; P. Rossi Ferrini (1997). Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.. JOURNAL OF CHEMOTHERAPY, vol. 9, pp. 95-101, ISSN:1120-009X

Samson, D; Volin, L; Schanz, U; Bosi, Alberto; Gahrtron, G. (1996). Feasibility and toxicity of interferon maintenance therapy after allogeneic BMT for multiple myeloma: a pilot study of the EBMT.. BONE MARROW TRANSPLANTATION, pp. 759-762, ISSN:1476-5365

A.Azzi; R.De Santis; S.Ciappi; F.Leoncini; G. Sterrantino; N. Marino; F.Mazzotta; D;Laszlo; R. Fanci; A. Bosi (1996). Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals. JOURNAL OF NEUROVIROLOGY, vol. 2, pp. 411-416, ISSN:1355-0284

Buggia, I; Zecca, M; Alessandrino, Ep; Locatelli, F; Rosti, G; Bosi, A; Pession, A; Rotoli, B; Majolino, I; Dallorso, A; Regazzi, Mb. (1996). . Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo).. ANTICANCER RESEARCH, pp. 2083-2088, ISSN:0250-7005

V. Santini; A. Zoccolante; A. Bosi; S. Guidi; R. Saccardi; A. M. Vannucchi; G. Martinazzo; P. A. Bernabei; P. R. Ferrini (1996). Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.. HAEMATOLOGICA, vol. 81, pp. 201-207, ISSN:0390-6078

A. M. Vannucchi; A. Bosi; A. Ieri; S. Guidi; R. Saccardi; L. Lombardini; S. Linari; D. Laszlo; G. Longo; P. Rossi-Ferrini (1996). Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.. BONE MARROW TRANSPLANTATION, vol. 17, pp. 527-531, ISSN:0268-3369

Gratwohl, A; Hermans, J; Apperley, J; Arcese, W; Bacigalupo, A; Bandini, G; di Bartolomeo, P; Boogaerts, M; Bosi, Alberto; Carreras, E. (1995). Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation.. BLOOD, pp. 813-818, ISSN:0006-4971

Porfirio B; Mattiuz PL; Chiarelli I; Guidi S; Bosi A (1995). PCR analysis of highly informative VNTR loci in the evaluation of chimerism after unrelated BMT. BONE MARROW TRANSPLANTATION, pp. 136-136, ISSN:0268-3369

Locasciulli, A; Alberti, A; Bandini, G; Polchi, P; Arcese, W; Alessandrino, P; Bosi, Alberto; Testa, M; Bacigalupo, A. (1995). Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).. BLOOD, pp. 3236-3240, ISSN:0006-4971

A. M. Vannucchi; A. Bosi; L. Lombardini; A. Grossi; P. Bacci; S. Guidi; R. Saccardi; P. Rossi-Ferrini (1995). Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.. EXPERIMENTAL HEMATOLOGY, vol. 23, pp. 1337-1340, ISSN:0301-472X

D.Laszlo ; A. Bosi ; S. Guidi ; R. Saccardi R; A. M .Vannucchi ; L.Lombardini;G. Longo ; R.Fanci ; A. Azzi ;R. De Santis ; PL . Rossi Ferrini. (1995). Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation.. HAEMATOLOGICA, vol. 80 (5), pp. 421-425, ISSN:0390-6078

A. M. Vannucchi; A. Bosi; D. Laszlo; S. Guidi; R. Saccardi; P. Rossi-Ferrini (1995). Treatment of a delayed graft failure after allogeneic bone marrow transplantation with IL-3 and GM-CSF.. HAEMATOLOGICA, vol. 80, pp. 341-343, ISSN:0390-6078

S. Porciani; A. Becciolini; A. Lanini; M. Storto; R. Saccardi; A. Bosi; S. Guidi; A.M. Vannucchi; L. Lombardini (1994). Erythrocyte polyamines in the monitoring of bone marrow transplantation.. In: Convegno, vol. Int. J. Biol. Markers vol. 9, pp. 160-160.

A. M. Vannucchi; A. Bost; A. Grossi; S. Guidi; R. Saccardi; P. Rossi-Ferrini (1994). Down-modulation of serum erythropoietin levels following cyclosporin A infusion.. BONE MARROW TRANSPLANTATION, vol. 13, pp. 497-498, ISSN:0268-3369

Ljungman, P; Biron, P; Bosi, A; Cahn, Jy; Goldstone, Ah; Gorin, Nc; Link, H; Messina, C; Michallet, M; Richard, C (1994). Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Infectious Disease Working Party of the European Group for Bone Marrow Transplantation.. BONE MARROW TRANSPLANTATION, pp. 209-212, ISSN:1476-5365

A. M. Vannucchi; D. Rafanelli; G. Longo; A. Bosi; S. Guidi; R. Saccardi; E. Filimberti; S. Cinotti; A. Grossi; M. Morfini (1994). Early hemostatic alterations following bone marrow transplantation: a prospective study.. HAEMATOLOGICA, vol. 79, pp. 519-525, ISSN:0390-6078

A. Azzi; R. Fanci; A. Bosi; S. Ciappi; K. Zakrzewska; R. de Santis; D. Laszlo; S. Guidi; R. Saccardi; A. M. Vannucchi (1994). Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis.. BONE MARROW TRANSPLANTATION, vol. 14, pp. 235-240, ISSN:0268-3369

Gratwohl, A; Hermans, J; Niederwieser, D; Frassoni, F; Arcese, W; Gahrton, G; Bandini, G; Carreras, E; Vernant, Jp; Bosi, A (1993). Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.. BONE MARROW TRANSPLANTATION, pp. 509-516, ISSN:1476-5365

Niederwieser, D; Arcese, W; Bandini, G; Schwaighofer, H; Thaler, J; Bosi, Alberto; Di Bartolomeo, P; Alessandrino, Ep; Urban, C; Gratwohl, A. (1993). Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.. SEMINARS IN HEMATOLOGY, pp. 40-43, ISSN:0037-1963

S. Porciani; A. Lanini; P. Comeglio; A. Tani; R. Saccardi; A. Bosi; S. Guidi; A.M. Vannucchi; A. Becciolini (1993). Significance of erythrocyte polyamines in bone marrow transplantation.. THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, vol. Int. J. Biol. Markers vol. 8, pp. 46-47, ISSN:0393-6155

R. Fanci ; F. Leoni ; A. Bosi ; S. Guidi ; S. Ciolli ; G. Longo ; E. Donnini ; P. Rossi Ferrini (1993). Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin.. JOURNAL OF CHEMOTHERAPY, vol. 5, pp. 119-123, ISSN:1120-009X

A. M. Vannucchi; A. Grossi; A. Bosi; D. Rafanelli; M. Statello; S. Guidi; R. Saccardi; P. Rossi-Ferrini (1993). Effects of cyclosporin A on erythropoietin production by the human Hep3B hepatoma cell line.. BLOOD, vol. 82, pp. 978-984, ISSN:0006-4971

A. Bosi; S. Guidi; A. Messori; R. Saccardi; L. Lombardini; A. M. Vannucchi; R. Fanci; P. Rossi-Ferrini (1993). Ondansetron versus chlorpromazine for preventing emesis in bone marrow transplant recipients: a double-blind randomized study.. JOURNAL OF CHEMOTHERAPY, vol. 5, pp. 191-196, ISSN:1120-009X

N. PIMPINELLI; P. ROMAGNOLI; A. BOSI; M. SANTUCCI; M. MORI; S. GUIDI; B. GIANNOTTI (1993). Dendritic cells in the skin after allogeneic bone marrow transplantation: immunohistochemical and electron microscopic monitoring. EUROPEAN JOURNAL OF DERMATOLOGY, vol. 3, pp. 310-317, ISSN:1167-1122

A. Azzi; R. Fanci; S. Ciappi; K. Zakrzewska; A. Bosi (1993). Human parvovirus B19 infection in bone marrow transplantation patients. AMERICAN JOURNAL OF HEMATOLOGY, vol. 44, pp. 207-209, ISSN:0361-8609

A. M. Vannucchi; A. Bosi; A. Grossi; S. Guidi; R. Saccardi; P. Bacci; L. Lombardini; P. Rossi-Ferrini (1993). The use of erythropoietin in the treatment of post-bone marrow transplantation anemia.. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, vol. 16 Suppl 5, pp. 8-12, ISSN:0391-3988

A. M. Vannucchi; A. Bosi; A. Grossi; S. Guidi; R. Saccardi; L. Lombardini; P. Rossi-Ferrini (1992). Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients.. LEUKEMIA, vol. 6, pp. 215-219, ISSN:0887-6924

N. PIMPINELLI; M. SANTUCCI; A. BOSI (1992). Localized scleroderma-like lesions in autologous bone marrow transplantation.. EUROPEAN JOURNAL OF DERMATOLOGY, vol. 2, pp. 12-14, ISSN:1167-1122

Biti, Gp; Cimino, G; Cartoni, C; Magrini, Sm; Anselmo, Ap; Enrici, Rm; Bellesi, Gp; Bosi, Alberto; Papa, G; Giannarelli, D. (1992). Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.. JOURNAL OF CLINICAL ONCOLOGY, pp. 378-382, ISSN:0732-183X

A. Messori; A. Bosi; S. Guidi; G. Longo; C. Pistolesi; R. Saccardi; T. Valenza; A. M. Vannucchi (1992). PKRD: a pharmacokinetic program for least-squares and bayesian analysis of repeated-dose pharmacokinetic curves.. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, vol. 38, pp. 27-35, ISSN:0169-2607

A. Bosi; R. Fanci; P. Pecile; S. Guidi; R. Saccardi; A. M. Vannucchi; G. Longo; E. Donnini; A. Orsi; P. Rossi-Ferrini (1992). Aztreonam versus colistin-neomycin for selective decontamination of the digestive tract in patients undergoing bone marrow transplantation: a randomized study.. JOURNAL OF CHEMOTHERAPY, vol. 4, pp. 30-34, ISSN:1120-009X

Paolo Romagnoli; Nicola Pimpinelli; Alberto Bosi; Stefano Bacci (1991). Human skin dendritic cells upon bone marrow transplantation (BMT) and graft versus host disease (GVHD) #162. EUROPEAN JOURNAL OF CELL BIOLOGY, vol. 55, pp. 162-162, ISSN:0171-9335

Cimino, G; Papa, G; Tura, S; Mazza, P; Rossi Ferrini, Pl; Bosi, A; Amadori, S; Lo Coco, F; D'Arcangelo, E; Giannarelli, D (1991). Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study. JOURNAL OF CLINICAL ONCOLOGY, pp. 432-437, ISSN:0732-183X

A. M. Vannucchi; A. Grossi; A. Bosi; D. Rafanelli; S. Guidi; R. Saccardi; R. Alterini; P. R. Ferrini (1991). Impaired erythropoietin production in mice treated with cyclosporin A.. BLOOD, vol. 78, pp. 1615-1618, ISSN:0006-4971

A. Bosi; A. M. Vannucchi; A. Grossi; S. Guidi; D. Rafanelli; R. Saccardi; P. R. Ferrini (1991). Serum erythropoietin levels in allogeneic, non T-depleted bone marrow transplantation, and the effects of rhEpo administration.. BONE MARROW TRANSPLANTATION, vol. 7 Suppl 2, pp. 87-87, ISSN:0268-3369

A. Bosi; A. M. Vannucchi; A. Grossi; S. Guidi; L. Vannucchi; R. Saccardi; P. A. Bernabei; G. Longo; D. Rafanelli; P. Rossi-Ferrini (1991). Serum erythropoietin levels in patients undergoing autologous bone marrow transplantation.. BONE MARROW TRANSPLANTATION, vol. 7, pp. 421-425, ISSN:0268-3369

A. M. Vannucchi; G. Longo; A. Bosi; S. Cinotti; E. Filimberti; S. Guidi; R. Saccardi; M. Morfini; E. Boni; P. Rossi Ferrini (1991). Early haemostatic modifications following cryopreserved graft infusion.. BONE MARROW TRANSPLANTATION, vol. 8, pp. 171-176, ISSN:0268-3369

A. Bosi; A. M. Vannucchi; A. Grossi; S. Guidi; R. Saccardi; D. Rafanelli; G. Longo; P. R. Ferrini (1991). Inadequate erythropoietin production in allogeneic bone marrow transplant patients.. HAEMATOLOGICA, vol. 76(4), pp. 280-284, ISSN:0390-6078

A. Bosi; E. De Majo; S. Guidi; F. Parri; R. Saccardi; A. M. Vannucchi; R. Fanci; P. R. Ferrini (1990). Kinetics of anti-CMV antibodies after administration of intravenous immunoglobulins to bone marrow transplant recipients.. HAEMATOLOGICA, vol. 75, pp. 109-112, ISSN:0390-6078

N. Pimpinelli; M. Santucci; P. Carli; M. Paglierani; A. Bosi; S. Moretti; B. Giannotti. (1990). Primary cutaneous follicular center cell lymphoma: clinical and pathological aspects.. In: vanVloten WA, Willemze R, Lange Vejlsgaard G, Thomsen K. Current Problems in Dermatology - Cutaneous lymphoma, pp. 203-220, Basel: Kargel.

F. PRIGNANO; M. MORI; M. ALAIBAC; M. SANTUCCI; N. PIMPINELLI; A. BOSI (1990). Lesioni cutanee «specifiche» in corso di leucemia linfatica cronica.. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, vol. 125, pp. 217-224, ISSN:0392-0488

A.Bosi; R.Fanci; P.Fossi Ferrini; L.Martelli; P.Pecile; S. Orsi; E.Faggi; E.Campisi;G.Gargani (1990). Surveillance mycologique chez les patients soumis à greffe de moelle osseuse à Florence.. BULLETIN DE LA SOCIETE FRANCAISE DE MYCOLOGIE MEDICALE, vol. 19, pp. 163-166, ISSN:0037-9336

Pimpinelli, Nicola; Santucci, Marco; Carli, P; Paglierani, M; Bosi, Alberto; Moretti, Silvia; Giannotti, B. (1990). Primary cutaneous follicular center cell lymphoma: clinical and histological aspects.. CURRENT PROBLEMS IN DERMATOLOGY-US, vol. 19, pp. 203-220, ISSN:1040-0486

S. Moretti; N. Pimpinelli; S. Di Lollo; C. Vallecchi; A. Bosi (1989). In situ immunologic characterization of cutaneous involvement in Hodgkin's disease.. CANCER, vol. 63, pp. 661-666, ISSN:1045-7410

F.Almerigogna; R.Biagiotti; MG.Giudizi; A.Alessi; M.Ricci; A.Bosi; S.Romagnani (1989). The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells.. LA RICERCA IN CLINICA E IN LABORATORIO, vol. 19, pp. 129-138, ISSN:0390-5748

N. Pimpinelli; M. Santucci; A. Bosi; C. Vallecchi; S. Moretti; P. Carli; L. Borgognoni; F. Prignano; M. Mori; B. Giannotti (1989). Primary cutaneous B-cell lymphomas: clinical and prognostic features. In: E. Panconesi. Proceedinds of the 1st Congress of the European Academy of Dermatology and Venereology, pp. 891-892, Oxford: BLACKWELL SCIENTIFIC PUBBLICATIONS.

R. Fanci ; A. Bosi; G. Longo; A. Bartoloni; D. Aquilini; A. Orsi; P. Rossi Ferrini (1989). Ofloxacin versus Cotrimoxazole for Prevention of Infections inGranulocytopenic Patients. REVISTA ESPANOLA DE QUIMIOTERAPIA, vol. 2, pp. 335-340, ISSN:0214-3429

Bartoloni A; Fanci R; Orsi A; Aquilini D; Bosi A; Rossi Ferrini P; Paradisi F (1989). The influence of ofloxacin versus trimethoprim-sulfamethoxazole on the aerobic flora in granulocytopenic subjects.. JOURNAL OF CHEMOTHERAPY, vol. 1, pp. 91-94, ISSN:1120-009X

Bellesi, G; Alterini, R; Messori, A; Bosi, A; Bernardi, F; di Lollo, S; Ferrini, Pr (1989). Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas.. BRITISH JOURNAL OF CANCER, pp. 244-248, ISSN:1532-1827

Cimino G;Biti GP;Anselmo AP;Maurizi Enrici R;Bellesi GP;Bosi A;Cionini L;Mungai V;Papa G;Ponticelli P (1989). MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease.. JOURNAL OF CLINICAL ONCOLOGY, vol. 7, pp. 732-737, ISSN:0732-183X

N. Pimpinelli; M. Santucci; A. Bosi; S. Moretti; C. Vallecchi; A. Messori; B. Giannotti (1989). Primary cutaneous follicular centre- cell lymphoma- a lymphoproliferative disease with favourable prognosis.. CLINICAL AND EXPERIMENTAL DERMATOLOGY, vol. 14, pp. 12-19, ISSN:0307-6938

Bosi A;Ponticelli P;Casini C;Messori A;Bellesi G;Biti G;Cionini L;Longo G;Mungai V;Rossi Ferrini P (1989). Clinical data and therapeutic approach in elderly patients with Hodgkin's disease.. HAEMATOLOGICA, vol. 74, pp. 463-473, ISSN:0390-6078

M. Stio; P. Vanni; P. Rossi Ferrini; E. Giachetti; A. Bosi; G. Pinzauti (1988). Neutral maltase of human granulocytes: localization on the extracytoplasmic side of the plasma membrane and some properties. BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, vol. 40, pp. 186-196, ISSN:0885-4505

Bosi, A; Messori, A; Casini, C; Bellesi, G; Longo, G; Rossi Ferrini, P. (1988). Prognostic factors in Hodgkin's disease.. THE LANCET, pp. 1117-1118, ISSN:0099-5355

Brusamolino, E; Papa, G; Valagussa, P; Mandelli, F; Bernasconi, C; Marmont, A; Bonadonna, G; Tura, S; Bosi, A; Mango, G (1987). Treatment-related leukemia in Hodgkin's disease: a multi-institution study on 75 cases.. HEMATOLOGICAL ONCOLOGY, pp. 83-98, ISSN:1099-1069

Rossi Ferrini, P; Bosi, A; Casini, C; Messori, A; Bellesi, G (1987). Hodgkin's disease in the elderly: a retrospective clinicopathologic study of 61 patients aged over 60 years.. ACTA HAEMATOLOGICA, pp. 163-170, ISSN:0001-5792

S. Moretti; A. Bosi; S. Di Lollo; N. Pimpinelli; B. Giannotti (1987). Phenotypic profile of cutaneous specific infiltrate in Hodgkin's disease. In: 7th ISD Colloquium, Graz, vol. 9, pp. 166-166.

S. Moretti; N. Pimpinelli; S. Di Lollo; P. Carli; A. Bosi (1987). Phenotypic profile of cutaneous specific infiltrate in Hodgkin's disease. ITALIAN GENERAL REVIEW OF DERMATOLOGY, vol. 24, pp. 103-105, ISSN:0021-292X

A. Bosi; N. Pimpinelli; M. Santucci; A. Messori; S. Moretti (1987). I linfomi primitivi cutanei a cellule del centro-follicolo: entità clinica a buona prognosi. HAEMATOLOGICA, vol. 3 (Suppl.), pp. 306-308, ISSN:0390-6078

E.Maggi; P.Parronchi; G.Del Prete; M.Ricci; A.Bosi; L.Moretta; S.Romagnani (1986). Frequent T4-positive cells with cytolytic activity in spleens of patients with Hodgkin’s disease (a clonal analysis). JOURNAL OF IMMUNOLOGY, vol. 136, pp. 1516-1520, ISSN:0022-1767

A. Bosi; S. Moretti; S. Di Lollo; G. Bellesi; N. Pimpinelli (1986). Interessamento cutaneo nel linfoma di Hodgkin: nuove osservazioni e tipizzazione immunologica dell’infiltrato. In: A. Cajozzo, R Perricone. Attualità in Ematologia, pp. 861-864, Bologna: MONDUZZI EDITORE.

P. Rossi Ferrini; A. Bosi; M. Stio; E. Giachetti; G. Pinzauti; P. Vanni (1986). On the neutral maltase of granulocytes membranes.XXI Congress of the International Society of Haematology - XIX Congress of the International Society of Blood Transfusion. Sidney, May 11-16 1986. Abs. P-TU-130-7. In: I.S.H., Sidney, ISH, pp. 452-452.

S. Moretti; A. Palermo; E. Donati; A. Bosi; A. Fattorossi. (1986). Phenotypic and ultrastructural profile of M5 leukemia cells in peripheral blood and skin infiltrate.. TUMORI, vol. 72, pp. 63-69, ISSN:0300-8916

E. Giachetti; G. Pinzauti; M. Stio; A. Bosi; P. Rossi Ferrini; P. Vanni (1984). Attività della maltasi neutra sulla membrana dei granulociti.31° Congresso Nazionale S.I.B. Rimini, 15-18 Settembre 1985. Abs. B21. In: S.I.B., Rimini, SIB, pp. 119-119.

Bosi, A; Borsotti, M; Ghelli, P; Tozzi, P; Bellesi, G; Rossi Ferrini, P (1984). Serum angiotensin-I-converting enzyme and lysozyme levels in untreated and unsplenectomized patients with Hodgkin's disease.. ACTA HAEMATOLOGICA, pp. 329-333, ISSN:0001-5792

Papa, G; Mauro, Fr; Anselmo, Ap; Cimino, G; Alimena, G; Amadori, S; D'Arcangelo, E; Giannarelli, D; Bosi, A; Bellesi, G (1984). Acute leukaemia in patients treated for Hodgkin's disease.. BRITISH JOURNAL OF HAEMATOLOGY, pp. 43-52, ISSN:0007-1048

A. Bosi; E. Giachetti; G. Pinzauti; P. Rossi Ferrini; M. Stio; P. Vanni (1984). Neutral Maltase Activity in Leucocytic PopulationNew Trends in Experimental Hematology, Serono Simposia. In: Serono, SERONO, pp. 392-394.

S.Romagnani; G.Del Prete; E.Maggi; A.Bosi; F.Bernardi; P.Ponticelli; S.Di Lollo; M.Ricci (1983). Displacement of T lymphocytes with the “helper/inducer” phenotype from peripheral blood to lymphoid organs in untreated patients with Hodgkin’s disease.. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, vol. 31, pp. 305-314, ISSN:0300-9475

Bellesi, G; di Lollo, S; Bosi, Alberto; Bernardi, F; Campana, G; Romagnani, S; Rossi Ferrini, P. (1982). Primary conjunctival lymphoma: response to chemotherapy in 4 cases.. ACTA HAEMATOLOGICA, pp. 161-162, ISSN:0001-5792

Baccarani, M; Bosi, A; Papa, G. (1980). Second malignancy in patients treated by Hodgkin's disease.. CANCER, pp. 1735-1740, ISSN:1097-0142